The	O
PEBP2betaMYH11	B-protein
fusion	O
created	O
by	O
Inv	B-DNA
(	I-DNA
16	I-DNA
)	I-DNA
(	I-DNA
p13	I-DNA
;	I-DNA
q22	I-DNA
)	I-DNA
in	O
myeloid	O
leukemia	O
impairs	O
neutrophil	O
maturation	O
and	O
contributes	O
to	O
granulocytic	O
dysplasia	O
.	O

Chromosomal	O
translocations	O
involving	O
the	O
genes	O
encoding	O
the	O
alpha	B-protein
and	I-protein
beta	I-protein
subunits	I-protein
of	O
the	O
Pebp2/Cbf	B-protein
transcription	I-protein
factor	I-protein
have	O
been	O
associated	O
with	O
human	O
acute	O
myeloid	O
leukemia	O
and	O
the	O
preleukemic	O
condition	O
,	O
myelodysplasia	O
.	O

Inv	B-DNA
(	I-DNA
16	I-DNA
)	I-DNA
(	I-DNA
p13	I-DNA
;	I-DNA
q22	I-DNA
)	I-DNA
fuses	O
the	O
gene	O
encoding	O
the	O
beta	B-protein
subunit	I-protein
of	O
Pebp2	B-protein
to	O
the	O
MYH11	B-DNA
gene	I-DNA
encoding	O
a	O
smooth	B-protein
muscle	I-protein
myosin	I-protein
heavy	I-protein
chain	I-protein
(	O
Smmhc	B-protein
)	O
.	O

To	O
examine	O
the	O
effect	O
of	O
the	O
inv	B-DNA
(	I-DNA
16	I-DNA
)	I-DNA
(	I-DNA
p13	I-DNA
;	I-DNA
q22	I-DNA
)	I-DNA
on	O
myelopoiesis	O
,	O
we	O
used	O
the	O
hMRP8	B-DNA
promoter	I-DNA
element	I-DNA
to	O
generate	O
transgenic	O
mice	O
expressing	O
the	O
Pebp2beta	B-protein
Smmhc	B-protein
chimeric	I-protein
fusion	I-protein
protein	I-protein
in	O
myeloid	B-cell_type
cells	I-cell_type
.	O

Neutrophil	O
maturation	O
was	O
impaired	O
in	O
PEBP2betaMYH11	B-protein
transgenic	O
mice	O
.	O

Although	O
the	O
transgenic	O
mice	O
had	O
normal	O
numbers	O
of	O
circulating	B-cell_type
neutrophils	I-cell_type
,	O
their	O
bone	O
marrow	O
contained	O
increased	O
numbers	O
of	O
immature	B-cell_type
neutrophilic	I-cell_type
cells	I-cell_type
,	O
which	O
exhibited	O
abnormal	O
characteristics	O
.	O

In	O
addition	O
,	O
PEBP2betaMYH11	B-protein
inhibited	O
neutrophilic	O
differentiation	O
in	O
colonies	O
derived	O
from	O
hematopoietic	B-cell_type
progenitors	I-cell_type
.	O

Coexpression	O
of	O
both	O
PEBP2betaMYH11	B-protein
and	O
activated	B-protein
NRAS	I-protein
induced	O
a	O
more	O
severe	O
phenotype	O
characterized	O
by	O
abnormal	O
nuclear	O
morphology	O
indicative	O
of	O
granulocytic	O
dysplasia	O
.	O

These	O
results	O
show	O
that	O
PEBP2betaMYH11	B-protein
can	O
impair	O
neutrophil	O
development	O
and	O
provide	O
evidence	O
that	O
alterations	O
of	O
Pebp2	B-protein
can	O
contribute	O
to	O
the	O
genesis	O
of	O
myelodysplasia	O
.	O

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
Vol	NULL
.	NULL

95	NULL
,	NULL
pp	NULL
.	NULL

11863-11868	NULL
,	NULL
September	NULL
1998	NULL
Medical	NULL
Sciences	NULL
The	NULL
PEBP2BMYH11	NULL
fusion	NULL
created	NULL
by	NULL
Inv	NULL
{	NULL
(	NULL
16	NULL
)	NULL
(	NULL
p13	NULL
;	NULL
q22	NULL
)	NULL
in	NULL
myeloid	NULL
leukemia	NULL
impairs	NULL
neutrophil	NULL
maturation	NULL
and	NULL
contributes	NULL
to	NULL
granulocytic	NULL
dysplasia	NULL
Scott	NULL
C	NULL
.	NULL

Kocan*	NULL
?	NULL

?	NULL

,	NULL
Eric	NULL
LagassE	NULL
$	NULL
§	NULL
,	NULL
Susan	NULL
AtwaTERtT	NULL
,	NULL
SUK-cHUuL	NULL
Bak	NULL
``	NULL
,	NULL
Irving	NULL
WEeissman	NULL
$	NULL
§	NULL
,	NULL
Troll	NULL
,	NULL
AND	NULL
J.	NULL
MicHaEL	NULL
BisHnoPp***ft	NULL
*G.	NULL
W.	NULL
Hooper	NULL
Foundation	NULL
and	NULL
Departments	NULL
of	NULL
**Biochemistry	NULL
and	NULL
Biophysics	NULL
and	NULL
*	NULL
!	NULL

Microbiology	NULL
and	NULL
Immunology	NULL
,	NULL
University	NULL
of	NULL
California	NULL
,	NULL
San	NULL
Francisco	NULL
,	NULL
CA	NULL
94143-0552	NULL
;	NULL
*Department	NULL
of	NULL
Laboratory	NULL
Medicine	NULL
,	NULL
University	NULL
of	NULL
California	NULL
,	NULL
San	NULL
Francisco	NULL
,	NULL
CA	NULL
94143-0100	NULL
;	NULL
$	NULL
Departments	NULL
of	NULL
Pathology	NULL
and	NULL
Developmental	NULL
Biology	NULL
,	NULL
Stanford	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Stanford	NULL
,	NULL
CA	NULL
94305	NULL
;	NULL
``	NULL
Department	NULL
of	NULL
Biochemistry	NULL
,	NULL
Chungbuk	NULL
National	NULL
University	NULL
,	NULL
Cheong-Ju	NULL
360-763	NULL
,	NULL
Korea	NULL
;	NULL
and	NULL
``	NULL
Institute	NULL
for	NULL
Virus	NULL
Research	NULL
,	NULL
Kyoto	NULL
University	NULL
,	NULL
Sakyo-ku	NULL
,	NULL
Kyoto	NULL
606-01	NULL
Japan	NULL
Contributed	NULL
by	NULL
J.	NULL
Michael	NULL
Bishop	NULL
,	NULL
July	NULL
28	NULL
,	NULL
1998	NULL
ABSTRACT	NULL
Chromosomal	NULL
translocations	NULL
involving	NULL
the	NULL
genes	NULL
encoding	NULL
the	NULL
alpha	NULL
and	NULL
beta	NULL
subunits	NULL
of	NULL
the	NULL
Pebp2/Cbf	NULL
transcription	NULL
factor	NULL
have	NULL
been	NULL
associated	NULL
with	NULL
human	NULL
acute	NULL
myeloid	NULL
leukemia	NULL
and	NULL
the	NULL
preleukemic	NULL
condition	NULL
,	NULL
myelodysplasia	NULL
.	NULL

Inv	NULL
(	NULL
16	NULL
)	NULL
(	NULL
p13	NULL
;	NULL
q22	NULL
)	NULL
fuses	NULL
the	NULL
gene	NULL
encoding	NULL
the	NULL
beta	NULL
subunit	NULL
of	NULL
Pebp2	NULL
to	NULL
the	NULL
MYHII	NULL
gene	NULL
encoding	NULL
a	NULL
smooth	NULL
muscle	NULL
myosin	NULL
heavy	NULL
chain	NULL
(	NULL
Smmhec	NULL
)	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
effect	NULL
of	NULL
the	NULL
inv	NULL
(	NULL
16	NULL
)	NULL
(	NULL
p13	NULL
;	NULL
q22	NULL
)	NULL
on	NULL
myelopoiesis	NULL
,	NULL
we	NULL
used	NULL
the	NULL
kMRPS8	NULL
promoter	NULL
element	NULL
to	NULL
generate	NULL
transgenic	NULL
mice	NULL
expressing	NULL
the	NULL
Pebp2BSmmhe	NULL
chimeric	NULL
fusion	NULL
protein	NULL
in	NULL
myeloid	NULL
cells	NULL
.	NULL

Neutrophil	NULL
maturation	NULL
was	NULL
impaired	NULL
in	NULL
PEBP2BMYH1I1	NULL
transgenic	NULL
mice	NULL
.	NULL

Although	NULL
the	NULL
transgenic	NULL
mice	NULL
had	NULL
normal	NULL
numbers	NULL
of	NULL
circulating	NULL
neutrophils	NULL
,	NULL
their	NULL
bone	NULL
marrow	NULL
contained	NULL
increased	NULL
numbers	NULL
of	NULL
immature	NULL
neutrophilic	NULL
cells	NULL
,	NULL
which	NULL
exhibited	NULL
abnormal	NULL
characteristics	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
PEBP2BMYH11	NULL
inhibited	NULL
neutrophilic	NULL
differentiation	NULL
in	NULL
colonies	NULL
derived	NULL
from	NULL
hematopoietic	NULL
progenitors	NULL
.	NULL

Coexpression	NULL
of	NULL
both	NULL
PEBP2BMYH11	NULL
and	NULL
activated	NULL
NRAS	NULL
induced	NULL
a	NULL
more	NULL
severe	NULL
phenotype	NULL
characterized	NULL
by	NULL
abnormal	NULL
nuclear	NULL
morphology	NULL
indicative	NULL
of	NULL
granulocytic	NULL
dysplasia	NULL
.	NULL

These	NULL
results	NULL
show	NULL
that	NULL
PEBP2BMYH11	NULL
can	NULL
impair	NULL
neutrophil	NULL
development	NULL
and	NULL
provide	NULL
evidence	NULL
that	NULL
alterations	NULL
of	NULL
Pebp2	NULL
can	NULL
contribute	NULL
to	NULL
the	NULL
genesis	NULL
of	NULL
myelodysplasia	NULL
.	NULL

Chromosomal	NULL
aberrations	NULL
play	NULL
critical	NULL
roles	NULL
in	NULL
the	NULL
pathogenesis	NULL
of	NULL
leukemias	NULL
.	NULL

A	NULL
recurrent	NULL
inversion	NULL
of	NULL
chromosome	NULL
16	NULL
,	NULL
inv	NULL
(	NULL
16	NULL
)	NULL
(	NULL
p13	NULL
;	NULL
q22	NULL
)	NULL
,	NULL
is	NULL
among	NULL
the	NULL
common	NULL
chromosomal	NULL
aberrations	NULL
associated	NULL
with	NULL
acute	NULL
nonlymphocytic	NULL
leukemia	NULL
(	NULL
1	NULL
)	NULL
.	NULL

This	NULL
inversion	NULL
fuses	NULL
the	NULL
gene	NULL
encoding	NULL
the	NULL
beta	NULL
subunit	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
Pebp2	NULL
(	NULL
also	NULL
known	NULL
as	NULL
Cbf	NULL
)	NULL
with	NULL
the	NULL
MYH11	NULL
gene	NULL
encoding	NULL
a	NULL
smooth	NULL
muscle	NULL
myosin	NULL
heavy	NULL
chain	NULL
(	NULL
Smmhe	NULL
)	NULL
(	NULL
2	NULL
)	NULL
.	NULL

The	NULL
resulting	NULL
PEBP2BMYH11	NULL
mRNA	NULL
transcript	NULL
encodes	NULL
the	NULL
bulk	NULL
of	NULL
the	NULL
Pebp2	NULL
$	NULL
protein	NULL
fused	NULL
to	NULL
the	NULL
a-helical	NULL
tail	NULL
of	NULL
Smmhe	NULL
(	NULL
2	NULL
)	NULL
.	NULL

Inv	NULL
(	NULL
16	NULL
)	NULL
(	NULL
p13	NULL
;	NULL
q22	NULL
)	NULL
is	NULL
closely	NULL
associated	NULL
with	NULL
acute	NULL
myelomonocytic	NULL
leukemia	NULL
with	NULL
eosinophilia	NULL
(	NULL
FAB	NULL
subtype	NULL
M4eo	NULL
)	NULL
(	NULL
3	NULL
)	NULL
.	NULL

PEBP2BMYH11	NULL
transcripts	NULL
can	NULL
be	NULL
detected	NULL
at	NULL
diagnosis	NULL
in	NULL
10	NULL
%	NULL
of	NULL
all	NULL
patients	NULL
with	NULL
acute	NULL
nonlymphocytic	NULL
leukemia	NULL
,	NULL
and	NULL
half	NULL
of	NULL
those	NULL
patients	NULL
have	NULL
a	NULL
diagnosis	NULL
of	NULL
M4eo	NULL
(	NULL
4	NULL
)	NULL
.	NULL

Pebp2/Cbf	NULL
is	NULL
a	NULL
heterodimeric	NULL
transcription	NULL
factor	NULL
composed	NULL
of	NULL
alpha	NULL
and	NULL
beta	NULL
subunits	NULL
(	NULL
5	NULL
,	NULL
6	NULL
)	NULL
.	NULL

The	NULL
alpha	NULL
subunit	NULL
binds	NULL
to	NULL
DNA	NULL
in	NULL
a	NULL
sequence-specific	NULL
fashion	NULL
,	NULL
whereas	NULL
the	NULL
beta	NULL
subunit	NULL
increases	NULL
the	NULL
affinity	NULL
of	NULL
this	NULL
binding	NULL
.	NULL

In	NULL
mammals	NULL
,	NULL
a	NULL
single	NULL
gene	NULL
encoding	NULL
Pebp2	NULL
$	NULL
has	NULL
been	NULL
identified	NULL
,	NULL
while	NULL
three	NULL
genes	NULL
encoding	NULL
alpha	NULL
subunits	NULL
are	NULL
present	NULL
.	NULL

One	NULL
of	NULL
the	NULL
three	NULL
alpha	NULL
genes	NULL
,	NULL
PEBP2	NULL
«	NULL
B/AML1/CBFA2	NULL
,	NULL
is	NULL
located	NULL
at	NULL
21422	NULL
.	NULL

This	NULL
gene	NULL
,	NULL
like	NULL
PEBP2	NULL
$	NULL
,	NULL
is	NULL
a	NULL
common	NULL
site	NULL
of	NULL
chromosomal	NULL
trans-	NULL
The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

§1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

©	NULL
1998	NULL
by	NULL
The	NULL
National	NULL
Academy	NULL
of	NULL
Sciences	NULL
0027-8424/98/9511863-6	NULL
$	NULL
2.00/0	NULL
PNAS	NULL
is	NULL
available	NULL
online	NULL
at	NULL
www.pnas.org	NULL
.	NULL

11863	NULL
locations	NULL
including	NULL
t	NULL
(	NULL
8	NULL
;	NULL
21	NULL
)	NULL
(	NULL
q22	NULL
;	NULL
q22	NULL
)	NULL
in	NULL
acute	NULL
myeloid	NULL
leukemia	NULL
(	NULL
7	NULL
)	NULL
,	NULL
t	NULL
(	NULL
3	NULL
;	NULL
21	NULL
)	NULL
(	NULL
q26	NULL
;	NULL
q22	NULL
)	NULL
in	NULL
myelodysplasia	NULL
and	NULL
blast	NULL
crisis	NULL
of	NULL
chronic	NULL
myelogenous	NULL
leukemia	NULL
(	NULL
8	NULL
,	NULL
9	NULL
)	NULL
,	NULL
and	NULL
t	NULL
(	NULL
12	NULL
;	NULL
21	NULL
)	NULL
(	NULL
p13	NULL
;	NULL
q22	NULL
)	NULL
in	NULL
pre-B	NULL
cell	NULL
acute	NULL
lymphocytic	NULL
leukemia	NULL
(	NULL
10	NULL
,	NULL
11	NULL
)	NULL
.	NULL

The	NULL
Pebp2	NULL
transcription	NULL
factor	NULL
is	NULL
believed	NULL
to	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
hematopoiesis	NULL
.	NULL

Pebp2	NULL
binding	NULL
sites	NULL
have	NULL
been	NULL
identified	NULL
in	NULL
a	NULL
large	NULL
number	NULL
of	NULL
genes	NULL
that	NULL
function	NULL
in	NULL
blood	NULL
cell	NULL
development	NULL
(	NULL
5	NULL
,	NULL
6	NULL
)	NULL
.	NULL

Pebp2	NULL
appears	NULL
to	NULL
regulate	NULL
these	NULL
genes	NULL
in	NULL
concert	NULL
with	NULL
other	NULL
transcription	NULL
factors	NULL
,	NULL
including	NULL
proteins	NULL
of	NULL
the	NULL
Myb	NULL
,	NULL
Ets	NULL
,	NULL
and	NULL
C/EBP	NULL
families	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Evidence	NULL
supporting	NULL
a	NULL
central	NULL
role	NULL
for	NULL
Pebp2	NULL
in	NULL
hematopoietic	NULL
development	NULL
was	NULL
provided	NULL
by	NULL
gene	NULL
knockout	NULL
experiments	NULL
.	NULL

Homozygous	NULL
disruption	NULL
of	NULL
either	NULL
the	NULL
Pebp2	NULL
«	NULL
B/Cbfa	NULL
or	NULL
the	NULL
Pebp2B/Cbfb	NULL
gene	NULL
blocks	NULL
the	NULL
development	NULL
of	NULL
definitive	NULL
he-matopoiesis	NULL
,	NULL
and	NULL
mice	NULL
lacking	NULL
either	NULL
of	NULL
these	NULL
genes	NULL
die	NULL
between	NULL
days	NULL
11.5	NULL
and	NULL
13.5	NULL
of	NULL
gestation	NULL
(	NULL
13-16	NULL
)	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
the	NULL
Pebp2BSmmhe	NULL
fusion	NULL
protein	NULL
on	NULL
hematopoiesis	NULL
was	NULL
investigated	NULL
by	NULL
inserting	NULL
the	NULL
3	NULL
'	NULL
part	NULL
of	NULL
the	NULL
human	NULL
MYH7	NULL
17	NULL
cDNA	NULL
into	NULL
the	NULL
mouse	NULL
Pebp2	NULL
$	NULL
B	NULL
gene	NULL
in	NULL
mouse	NULL
embryonic	NULL
stem	NULL
cells	NULL
(	NULL
17	NULL
)	NULL
.	NULL

The	NULL
authors	NULL
demonstrated	NULL
that	NULL
expression	NULL
of	NULL
Pebp2BMYH11	NULL
during	NULL
embryonic	NULL
development	NULL
can	NULL
,	NULL
like	NULL
the	NULL
loss	NULL
of	NULL
Pebp2aB	NULL
or	NULL
Pebp2	NULL
$	NULL
B	NULL
,	NULL
abrogate	NULL
definitive	NULL
hematopoiesis	NULL
.	NULL

These	NULL
results	NULL
suggested	NULL
that	NULL
Pebp2BSmmhe	NULL
can	NULL
exhibit	NULL
dominant	NULL
negative	NULL
activity	NULL
.	NULL

However	NULL
,	NULL
because	NULL
embryonic	NULL
stem	NULL
cells	NULL
carrying	NULL
the	NULL
Pebp2BMYH11	NULL
allele	NULL
did	NULL
not	NULL
contribute	NULL
to	NULL
mature	NULL
hemato-poictic	NULL
tissues	NULL
,	NULL
the	NULL
effects	NULL
of	NULL
the	NULL
fusion	NULL
gene	NULL
on	NULL
myeloid	NULL
differentiation	NULL
could	NULL
not	NULL
be	NULL
assessed	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
effects	NULL
of	NULL
Pebp2BSmmhe	NULL
on	NULL
myelopoiesis	NULL
we	NULL
generated	NULL
transgenic	NULL
mice	NULL
in	NULL
which	NULL
expression	NULL
of	NULL
Pebp2BSmmhe	NULL
was	NULL
targeted	NULL
to	NULL
myeloid	NULL
cells	NULL
.	NULL

Our	NULL
results	NULL
demonstrate	NULL
that	NULL
Pebp26Smmhe	NULL
impairs	NULL
neutrophilic	NULL
maturation	NULL
and	NULL
can	NULL
cooperate	NULL
with	NULL
activated	NULL
Ras	NULL
to	NULL
promote	NULL
markedly	NULL
aberrant	NULL
neutrophilic	NULL
differentiation	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Generation	NULL
of	NULL
Transgenic	NULL
Mice	NULL
.	NULL

A	NULL
human	NULL
PEBP2BMYH11	NULL
cDNA	NULL
(	NULL
18	NULL
)	NULL
was	NULL
cloned	NULL
into	NULL
the	NULL
hMRPS8	NULL
expression	NULL
cassette	NULL
(	NULL
19	NULL
)	NULL
.	NULL

The	NULL
Xbal	NULL
fragment	NULL
containing	NULL
the	NULL
PEBP2BMYH11	NULL
cDNA	NULL
was	NULL
recloned	NULL
into	NULL
pBluescript	NULL
II	NULL
KS+	NULL
(	NULL
Stratagene	NULL
)	NULL
so	NULL
that	NULL
a	NULL
BamHI	NULL
fragment	NULL
containing	NULL
the	NULL
cDNA	NULL
then	NULL
could	NULL
be	NULL
transferred	NULL
into	NULL
the	NULL
Bg/II	NULL
site	NULL
of	NULL
the	NULL
hMRP8	NULL
cassette	NULL
.	NULL

hMRPS8-NRAS	NULL
``	NULL
``	NULL
``	NULL
was	NULL
similarly	NULL
prepared	NULL
by	NULL
using	NULL
a	NULL
BamHI	NULL
fragment	NULL
containing	NULL
the	NULL
NRAS	NULL
@	NULL
2	NULL
``	NULL
cDNA	NULL
.	NULL

Transgenic	NULL
animals	NULL
were	NULL
prepared	NULL
following	NULL
standard	NULL
procedures	NULL
(	NULL
20	NULL
)	NULL
from	NULL
inbred	NULL
FVB/N	NULL
mice	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Abbreviations	NULL
:	NULL
Smmhe	NULL
,	NULL
smooth	NULL
muscle	NULL
myosin	NULL
heavy	NULL
chain	NULL
;	NULL
G	NULL
,	NULL
granulo-	NULL
cyte	NULL
;	NULL
GM	NULL
,	NULL
granulocyte/macrophage	NULL
;	NULL
CSF	NULL
,	NULL
colony-stimulating	NULL
factor	NULL
.	NULL

whom	NULL
reprint	NULL
requests	NULL
should	NULL
be	NULL
addressed	NULL
at	NULL
:	NULL
Hooper	NULL
Founda-tion	NULL
,	NULL
HSW-1501	NULL
,	NULL
513	NULL
Parnassus	NULL
Avenue	NULL
,	NULL
University	NULL
of	NULL
California	NULL
,	NULL
San	NULL
Francisco	NULL
,	NULL
CA	NULL
94143-0552.	NULL
e-mail	NULL
:	NULL
skogan	NULL
@	NULL
cgl.ucsf.edu	NULL
.	NULL

11864	NULL
_	NULL
Medical	NULL
Sciences	NULL
:	NULL
Kogan	NULL
et	NULL
al	NULL
.	NULL

Western	NULL
Blotting	NULL
.	NULL

Control	NULL
cell	NULL
lines	NULL
were	NULL
generated	NULL
by	NULL
cloning	NULL
lacZ	NULL
and	NULL
PEBP2BMYH11	NULL
cDNAs	NULL
into	NULL
the	NULL
MSCV	NULL
v2.1	NULL
retroviral	NULL
vector	NULL
(	NULL
22	NULL
)	NULL
,	NULL
transfecting	NULL
the	NULL
cDNAs	NULL
into	NULL
BOSC23	NULL
cells	NULL
to	NULL
generate	NULL
retroviral	NULL
stocks	NULL
(	NULL
23	NULL
)	NULL
,	NULL
followed	NULL
by	NULL
infection	NULL
and	NULL
selection	NULL
of	NULL
pools	NULL
of	NULL
NIH	NULL
3T3	NULL
cells	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Western	NULL
blotting	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
(	NULL
25	NULL
)	NULL
with	NULL
rabbit	NULL
polyclonal	NULL
antiserum	NULL
raised	NULL
against	NULL
Pebp2	NULL
$	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Whole-cell	NULL
lysates	NULL
of	NULL
tissue	NULL
culture	NULL
fibroblasts	NULL
and	NULL
of	NULL
tissues	NULL
from	NULL
control	NULL
and	NULL
transgenic	NULL
mice	NULL
were	NULL
subjected	NULL
to	NULL
denaturing	NULL
PAGE	NULL
on	NULL
an	NULL
8	NULL
%	NULL
SDS-polyacrylamide	NULL
gel	NULL
and	NULL
then	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
.	NULL

Isolation	NULL
of	NULL
Cells	NULL
from	NULL
Tissues	NULL
.	NULL

Blood	NULL
was	NULL
obtained	NULL
from	NULL
anesthetized	NULL
animals	NULL
by	NULL
venipuncture	NULL
of	NULL
the	NULL
retro-orbital	NULL
venous	NULL
plexus	NULL
.	NULL

Bone	NULL
marrow	NULL
was	NULL
obtained	NULL
by	NULL
flushing	NULL
Hank	NULL
's	NULL
balanced	NULL
salt	NULL
solution	NULL
through	NULL
mouse	NULL
long	NULL
bones	NULL
,	NULL
followed	NULL
by	NULL
filtering	NULL
through	NULL
nylon	NULL
mesh	NULL
.	NULL

When	NULL
necessary	NULL
,	NULL
red	NULL
cells	NULL
were	NULL
lysed	NULL
with	NULL
ammonium	NULL
chloride	NULL
potassium	NULL
lysing	NULL
buffer	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Blood	NULL
smears	NULL
,	NULL
bone	NULL
marrow	NULL
smears	NULL
,	NULL
and	NULL
cytospins	NULL
were	NULL
prepared	NULL
according	NULL
to	NULL
standard	NULL
hematological	NULL
techniques	NULL
.	NULL

Immunofluorescence	NULL
.	NULL

Cytospins	NULL
of	NULL
bone	NULL
marrow	NULL
cells	NULL
were	NULL
fixed	NULL
for	NULL
20	NULL
min	NULL
in	NULL
3.7	NULL
%	NULL
paraformaldehyde	NULL
in	NULL
PBS	NULL
and	NULL
permeabilized	NULL
for	NULL
10	NULL
min	NULL
with	NULL
0.1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
in	NULL
PBS	NULL
.	NULL

Samples	NULL
were	NULL
blocked	NULL
for	NULL
15	NULL
min	NULL
in	NULL
PBS	NULL
with	NULL
10	NULL
%	NULL
normal	NULL
goat	NULL
serum	NULL
(	NULL
NGS	NULL
)	NULL
and	NULL
incubated	NULL
for	NULL
1	NULL
hr	NULL
with	NULL
the	NULL
rabbit	NULL
polyclonal	NULL
antiserum	NULL
raised	NULL
against	NULL
Pebp2	NULL
$	NULL
diluted	NULL
1:200	NULL
in	NULL
PBS/NGS	NULL
.	NULL

Washing	NULL
with	NULL
PBS/NGS	NULL
was	NULL
followed	NULL
by	NULL
30	NULL
min	NULL
of	NULL
incubation	NULL
with	NULL
Texas	NULL
Red-labeled	NULL
goat	NULL
anti-rabbit	NULL
IgG	NULL
(	NULL
Southern	NULL
Biotechnology	NULL
Associates	NULL
)	NULL
at	NULL
1:800	NULL
in	NULL
PBS/NGS	NULL
.	NULL

The	NULL
slides	NULL
were	NULL
washed	NULL
with	NULL
PBS/NGS	NULL
and	NULL
mounted	NULL
in	NULL
Prolong	NULL
medium	NULL
(	NULL
Molecular	NULL
Probes	NULL
)	NULL
plus	NULL
0.1	NULL
ug/ml	NULL
of	NULL
Hoechst33258	NULL
.	NULL

Cell	NULL
Staining	NULL
and	NULL
Statistical	NULL
Analyses	NULL
.	NULL

Slides	NULL
were	NULL
stained	NULL
with	NULL
Wright-Giemsa	NULL
and	NULL
Azure	NULL
B	NULL
dyes	NULL
(	NULL
Curtin	NULL
Matheson	NULL
Scientific	NULL
,	NULL
Houston	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
directions	NULL
.	NULL

Differential	NULL
cell	NULL
counts	NULL
were	NULL
performed	NULL
without	NULL
knowledge	NULL
of	NULL
specimen	NULL
identifications	NULL
.	NULL

Statistical	NULL
comparisons	NULL
were	NULL
done	NULL
by	NULL
using	NULL
the	NULL
Student	NULL
's	NULL
£	NULL
test	NULL
.	NULL

Results	NULL
are	NULL
shown	NULL
as	NULL
arithmetic	NULL
means	NULL
+	NULL
SD	NULL
.	NULL

Morphologic	NULL
dysplasia	NULL
of	NULL
bone	NULL
marrow	NULL
neutrophlilic	NULL
cells	NULL
was	NULL
quantitatively	NULL
assessed	NULL
by	NULL
performing	NULL
differential	NULL
cell	NULL
counts	NULL
(	NULL
total	NULL
of	NULL
400	NULL
cells	NULL
each	NULL
)	NULL
on	NULL
bone	NULL
marrow	NULL
smears	NULL
.	NULL

Percentages	NULL
of	NULL
total	NULL
mature	NULL
neutrophilic	NULL
cells	NULL
(	NULL
normal	NULL
mature	NULL
ring	NULL
forms	NULL
,	NULL
aberrant	NULL
band	NULL
forms	NULL
,	NULL
and	NULL
polymorphonuclear	NULL
forms	NULL
)	NULL
with	NULL
dysplastic	NULL
features	NULL
(	NULL
band	NULL
forms	NULL
and	NULL
forms	NULL
with	NULL
bi-lobed	NULL
or	NULL
multi-lobed	NULL
nuclei	NULL
)	NULL
were	NULL
determined	NULL
.	NULL

Peripheral	NULL
Blood	NULL
Counts	NULL
.	NULL

Blood	NULL
collected	NULL
from	NULL
7-to-9-week-old	NULL
mice	NULL
was	NULL
analyzed	NULL
on	NULL
a	NULL
Technicon	NULL
H-3	NULL
automated	NULL
hematology	NULL
analyzer	NULL
to	NULL
assess	NULL
white	NULL
blood	NULL
cell	NULL
counts	NULL
,	NULL
hemo-globin	NULL
,	NULL
and	NULL
platelet	NULL
counts	NULL
by	NULL
using	NULL
the	NULL
standard	NULL
software	NULL
for	NULL
clinical	NULL
analysis	NULL
.	NULL

The	NULL
Technicon	NULL
H-3	NULL
uses	NULL
a	NULL
cytochemical	NULL
assay	NULL
to	NULL
measure	NULL
leukocyte	NULL
myeloperoxidase	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Differential	NULL
white	NULL
blood	NULL
cell	NULL
counts	NULL
(	NULL
total	NULL
of	NULL
200	NULL
cells	NULL
each	NULL
)	NULL
were	NULL
performed	NULL
on	NULL
peripheral	NULL
blood	NULL
smears	NULL
.	NULL

The	NULL
proportions	NULL
of	NULL
cells	NULL
morphologically	NULL
identified	NULL
as	NULL
lymphocytic	NULL
,	NULL
neutrophilic	NULL
,	NULL
monocytic	NULL
,	NULL
and	NULL
eosinophilic	NULL
were	NULL
multiplied	NULL
by	NULL
total	NULL
white	NULL
blood	NULL
cell	NULL
counts	NULL
to	NULL
obtain	NULL
absolute	NULL
numbers	NULL
.	NULL

Density	NULL
Fractionation	NULL
.	NULL

Bone	NULL
marrow	NULL
cells	NULL
were	NULL
separated	NULL
by	NULL
density	NULL
gradient	NULL
fractionation	NULL
by	NULL
using	NULL
a	NULL
modification	NULL
of	NULL
a	NULL
previously	NULL
published	NULL
method	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Percoll	NULL
(	NULL
Pharmacia	NULL
Bio-tech	NULL
)	NULL
solutions	NULL
(	NULL
45	NULL
%	NULL
,	NULL
62	NULL
%	NULL
,	NULL
and	NULL
81	NULL
%	NULL
)	NULL
were	NULL
prepared	NULL
as	NULL
previously	NULL
described	NULL
.	NULL

After	NULL
red	NULL
blood	NULL
cell	NULL
lysis	NULL
,	NULL
1	NULL
X	NULL
10	NULL
``	NULL
nucleated	NULL
bone	NULL
marrow	NULL
cells	NULL
were	NULL
resuspended	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
45	NULL
%	NULL
Percoll	NULL
solution	NULL
and	NULL
layered	NULL
onto	NULL
a	NULL
step-gradient	NULL
composed	NULL
of	NULL
1	NULL
ml	NULL
of	NULL
62	NULL
%	NULL
Percoll	NULL
solution	NULL
and	NULL
1	NULL
ml	NULL
of	NULL
81	NULL
%	NULL
Percoll	NULL
solution	NULL
in	NULL
12	NULL
X	NULL
75	NULL
mm	NULL
polystyrene	NULL
tubes	NULL
.	NULL

The	NULL
samples	NULL
were	NULL
centrifuged	NULL
at	NULL
approximately	NULL
1,600	NULL
g	NULL
for	NULL
30	NULL
min	NULL
at	NULL
10°C	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
from	NULL
the	NULL
two	NULL
interfaces	NULL
and	NULL
counted	NULL
,	NULL
and	NULL
cytospins	NULL
were	NULL
prepared	NULL
.	NULL

Total	NULL
cell	NULL
counts	NULL
and	NULL
differential	NULL
counts	NULL
were	NULL
used	NULL
to	NULL
calculate	NULL
the	NULL
mean	NULL
percentages	NULL
of	NULL
neutrophilic	NULL
cells	NULL
present	NULL
in	NULL
the	NULL
high	NULL
density	NULL
fractions	NULL
.	NULL

MethylIcellulose	NULL
Cultures	NULL
of	NULL
Bone	NULL
Marrow	NULL
.	NULL

Bone	NULL
marrow	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
duplicate	NULL
in	NULL
35-mm	NULL
Petri	NULL
dishes	NULL
in	NULL
Methocult	NULL
M3230	NULL
methylcellulose	NULL
medium	NULL
(	NULL
StemCell	NULL
Tech-	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
95	NULL
(	NULL
1998	NULL
)	NULL
nologies	NULL
,	NULL
Vancouver	NULL
,	NULL
BC	NULL
)	NULL
supplemented	NULL
with	NULL
either	NULL
2	NULL
%	NULL
pokeweed	NULL
mitogen	NULL
spleen	NULL
conditioned	NULL
media	NULL
(	NULL
PWM-SCM	NULL
)	NULL
(	NULL
StemCell	NULL
Technologies	NULL
)	NULL
,	NULL
50	NULL
units/ml	NULL
of	NULL
granulocyte	NULL
colony-stimulating	NULL
factor	NULL
(	NULL
G-CSF	NULL
)	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
)	NULL
,	NULL
or	NULL
20	NULL
ng/ml	NULL
of	NULL
granulocyte/macrophage	NULL
(	NULL
GM	NULL
)	NULL
-CSF	NULL
(	NULL
StemCell	NULL
Technologies	NULL
)	NULL
.	NULL

One-milliliter	NULL
cultures	NULL
contained	NULL
either	NULL
5	NULL
X	NULL
10	NULL
%	NULL
(	NULL
PWM-SCM	NULL
,	NULL
G-CSF	NULL
,	NULL
GM-CSF	NULL
)	NULL
or	NULL
2.5	NULL
x	NULL
10°	NULL
(	NULL
G-CSF	NULL
)	NULL
viable	NULL
bone	NULL
marrow	NULL
cells	NULL
.	NULL

Cultures	NULL
were	NULL
examined	NULL
at	NULL
7	NULL
days	NULL
.	NULL

Colonies	NULL
were	NULL
counted	NULL
on	NULL
an	NULL
inverted	NULL
light	NULL
microscope	NULL
.	NULL

Duplicate	NULL
plates	NULL
were	NULL
averaged	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
,	NULL
pelleted	NULL
,	NULL
washed	NULL
once	NULL
in	NULL
Hank	NULL
's	NULL
balanced	NULL
salt	NULL
solution	NULL
,	NULL
and	NULL
counted	NULL
before	NULL
the	NULL
preparation	NULL
of	NULL
cytospins	NULL
.	NULL

Differential	NULL
cell	NULL
counts	NULL
(	NULL
total	NULL
of	NULL
400	NULL
cells	NULL
each	NULL
)	NULL
were	NULL
performed	NULL
to	NULL
assess	NULL
percentages	NULL
and	NULL
absolute	NULL
numbers	NULL
of	NULL
neutrophilic	NULL
cells	NULL
.	NULL

Transplantation	NULL
of	NULL
Bone	NULL
Marrow	NULL
.	NULL

Bone	NULL
marrow	NULL
isolated	NULL
from	NULL
donors	NULL
was	NULL
transplanted	NULL
into	NULL
irradiated	NULL
FVB/N	NULL
mice	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
29	NULL
)	NULL
.	NULL

RESULTS	NULL
Expression	NULL
of	NULL
PEBP2BMYH11	NULL
in	NULL
Transgenic	NULL
Mice	NULL
.	NULL

The	NULL
small	NULL
calcium-binding	NULL
protein	NULL
Mrp8	NULL
is	NULL
expressed	NULL
in	NULL
myeloid	NULL
cells	NULL
of	NULL
the	NULL
neutrophil	NULL
and	NULL
monocyte	NULL
lineages	NULL
(	NULL
30	NULL
)	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
effects	NULL
of	NULL
the	NULL
PEBP2BMYH1I1	NULL
fusion	NULL
gene	NULL
on	NULL
myelopoiesis	NULL
,	NULL
we	NULL
created	NULL
mice	NULL
that	NULL
expressed	NULL
a	NULL
human	NULL
PEBP2BMYH11	NULL
cDNA	NULL
(	NULL
18	NULL
)	NULL
from	NULL
the	NULL
hMRP8	NULL
promoter	NULL
cassette	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
.	NULL

Injections	NULL
into	NULL
FVB/N	NULL
embryos	NULL
yielded	NULL
four	NULL
transgenic	NULL
lines	NULL
.	NULL

As	NULL
assessed	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
with	NULL
a	NULL
polyclonal	NULL
anti-Pebp2	NULL
$	NULL
antiserum	NULL
(	NULL
18	NULL
)	NULL
,	NULL
the	NULL
transgene	NULL
was	NULL
highly	NULL
expressed	NULL
in	NULL
bone	NULL
marrow	NULL
cells	NULL
of	NULL
lines	NULL
Tg259	NULL
and	NULL
Tg237	NULL
.	NULL

Only	NULL
trace	NULL
amounts	NULL
of	NULL
the	NULL
chimeric	NULL
protein	NULL
were	NULL
detected	NULL
in	NULL
spleen	NULL
cells	NULL
consistent	NULL
with	NULL
a	NULL
lack	NULL
of	NULL
expression	NULL
in	NULL
lymphocytes	NULL
.	NULL

No	NULL
expression	NULL
of	NULL
the	NULL
transgene	NULL
was	NULL
found	NULL
in	NULL
thymus	NULL
or	NULL
liver	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

These	NULL
results	NULL
corresponded	NULL
to	NULL
the	NULL
described	NULL
myeloid	NULL
A	NULL
49	NULL
%	NULL
1921	NULL
HMRP8	NULL
Promoter	NULL
u	NULL
E	NULL
Bone	NULL
Marrow	NULL
Spleen	NULL
Thymus	NULL
Liver	NULL
R	NULL
e	NULL
a	NULL
$	NULL
as	NULL
Zo	NULL
cs	NULL
Z	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

(	NULL
4	NULL
)	NULL
Map	NULL
of	NULL
the	NULL
transgene	NULL
.	NULL

The	NULL
PEBP2BMYH1T1	NULL
cDNA	NULL
inserted	NULL
into	NULL
the	NULL
BglII	NULL
site	NULL
of	NULL
the	NULL
human	NULL
MRP8	NULL
promoter	NULL
cassette	NULL
corresponded	NULL
to	NULL
the	NULL
most	NULL
common	NULL
inv	NULL
(	NULL
16	NULL
)	NULL
breakpoint	NULL
.	NULL

The	NULL
nucleotide	NULL
locations	NULL
of	NULL
the	NULL
breakpoint	NULL
within	NULL
the	NULL
coding	NULL
sequences	NULL
of	NULL
PEBP2G	NULL
and	NULL
MYH11	NULL
are	NULL
shown	NULL
.	NULL

White	NULL
boxes	NULL
represent	NULL
noncoding	NULL
portions	NULL
of	NULL
MRPS8	NULL
exons	NULL
.	NULL

Solid	NULL
lines	NULL
represent	NULL
5	NULL
'	NULL
and	NULL
3	NULL
'	NULL
flanking	NULL
sequences	NULL
and	NULL
intron	NULL
1	NULL
of	NULL
MRP38	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Expression	NULL
of	NULL
the	NULL
transgene	NULL
.	NULL

Whole-cell	NULL
lysates	NULL
were	NULL
subjected	NULL
to	NULL
denaturing	NULL
PAGE	NULL
and	NULL
Western	NULL
blotting	NULL
using	NULL
a	NULL
rabbit	NULL
polyclonal	NULL
anti-Pebp2	NULL
$	NULL
antiserum	NULL
.	NULL

The	NULL
signal	NULL
at	NULL
70	NULL
kDa	NULL
corresponds	NULL
to	NULL
the	NULL
Pebp2§Smmhe	NULL
protein	NULL
.	NULL

The	NULL
first	NULL
two	NULL
lanes	NULL
are	NULL
lysates	NULL
of	NULL
NIH	NULL
3T3	NULL
cells	NULL
that	NULL
contained	NULL
retroviral	NULL
vectors	NULL
expressing	NULL
either	NULL
a	NULL
lacZ	NULL
or	NULL
a	NULL
PEBP2BMYH11	NULL
cDNA	NULL
.	NULL

The	NULL
remaining	NULL
lanes	NULL
are	NULL
lysates	NULL
of	NULL
tissues	NULL
from	NULL
control	NULL
FVB/N	NULL
mice	NULL
or	NULL
transgenic	NULL
mice	NULL
of	NULL
lines	NULL
Tg259	NULL
or	NULL
Tg237	NULL
.	NULL

(	NULL
C-F	NULL
)	NULL
Immunofluorescence	NULL
of	NULL
bone	NULL
marrow	NULL
neutrophilic	NULL
cells	NULL
.	NULL

(	NULL
C	NULL
and	NULL
D	NULL
)	NULL
Control	NULL
.	NULL

(	NULL
E	NULL
and	NULL
F	NULL
)	NULL
Tg237	NULL
.	NULL

(	NULL
C	NULL
and	NULL
E	NULL
)	NULL
Anti-Pebp28	NULL
antiserum	NULL
.	NULL

(	NULL
D	NULL
and	NULL
F	NULL
)	NULL
Hoechst	NULL
33258	NULL
.	NULL

(	NULL
Original	NULL
magnification	NULL
,	NULL
X250	NULL
.	NULL
)	NULL

Medical	NULL
Sciences	NULL
:	NULL
Kogan	NULL
et	NULL
al	NULL
.	NULL

expression	NULL
pattern	NULL
for	NULL
the	NULL
hMRPS8	NULL
promoter	NULL
cassette	NULL
.	NULL

By	NULL
Western	NULL
blot	NULL
analysis	NULL
,	NULL
line	NULL
Tg237	NULL
expressed	NULL
higher	NULL
levels	NULL
of	NULL
the	NULL
Pebp2BSmmhe	NULL
fusion	NULL
protein	NULL
than	NULL
did	NULL
line	NULL
Tg259	NULL
.	NULL

Only	NULL
low	NULL
levels	NULL
of	NULL
expression	NULL
were	NULL
observed	NULL
in	NULL
cells	NULL
derived	NULL
from	NULL
our	NULL
other	NULL
two	NULL
transgenic	NULL
lines	NULL
,	NULL
and	NULL
those	NULL
lines	NULL
were	NULL
not	NULL
further	NULL
analyzed	NULL
.	NULL

Immunofluorescent	NULL
study	NULL
of	NULL
bone	NULL
marrow	NULL
cells	NULL
derived	NULL
from	NULL
control	NULL
and	NULL
Tg237	NULL
transgenic	NULL
mice	NULL
revealed	NULL
expression	NULL
in	NULL
transgenic	NULL
neutrophilic	NULL
cells	NULL
with	NULL
characteristic	NULL
ring-shaped	NULL
nuclei	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
C-F	NULL
)	NULL
.	NULL

Pebp2BSmmhe	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
be	NULL
localized	NULL
to	NULL
the	NULL
cytoplasm	NULL
and	NULL
to	NULL
the	NULL
nucleus	NULL
(	NULL
18	NULL
,	NULL
31-33	NULL
)	NULL
.	NULL

A	NULL
speckled	NULL
and	NULL
rod-like	NULL
nuclear	NULL
staining	NULL
,	NULL
similar	NULL
to	NULL
a	NULL
pattern	NULL
previously	NULL
observed	NULL
in	NULL
some	NULL
but	NULL
not	NULL
all	NULL
cell	NULL
types	NULL
(	NULL
32	NULL
)	NULL
,	NULL
was	NULL
observed	NULL
in	NULL
neutrophilic	NULL
cells	NULL
from	NULL
transgenic	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
£	NULL
)	NULL
but	NULL
not	NULL
control	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
bone	NULL
marrow	NULL
.	NULL

PEBP2BMYH11	NULL
Transgenic	NULL
Mice	NULL
Are	NULL
Healthy	NULL
and	NULL
Maintain	NULL
Normal	NULL
Numbers	NULL
of	NULL
Peripheral	NULL
Blood	NULL
Neutrophils	NULL
.	NULL

Expression	NULL
of	NULL
from	NULL
native	NULL
PEBP2B	NULL
control	NULL
elements	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
abrogate	NULL
definitive	NULL
hematopoiesis	NULL
and	NULL
result	NULL
in	NULL
embryonic	NULL
lethality	NULL
(	NULL
17	NULL
)	NULL
.	NULL

However	NULL
,	NULL
by	NULL
driving	NULL
expression	NULL
of	NULL
PEBP2BMYH11	NULL
from	NULL
the	NULL
kMRPS8	NULL
promoter	NULL
element	NULL
that	NULL
is	NULL
not	NULL
expressed	NULL
in	NULL
hematopoietic	NULL
stem	NULL
cells	NULL
(	NULL
E.L.	NULL
,	NULL
unpublished	NULL
data	NULL
)	NULL
we	NULL
were	NULL
able	NULL
to	NULL
derive	NULL
healthy	NULL
mice	NULL
that	NULL
expressed	NULL
high	NULL
levels	NULL
of	NULL
the	NULL
Pebp28Smmhe	NULL
protein	NULL
in	NULL
their	NULL
bone	NULL
marrow	NULL
.	NULL

The	NULL
peripheral	NULL
blood	NULL
cell	NULL
counts	NULL
of	NULL
these	NULL
mice	NULL
were	NULL
normal	NULL
,	NULL
including	NULL
normal	NULL
numbers	NULL
of	NULL
circulating	NULL
mature	NULL
neutrophils	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
morphology	NULL
of	NULL
these	NULL
transgenic	NULL
neutrophils	NULL
differed	NULL
from	NULL
that	NULL
of	NULL
control	NULL
neutrophils	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
4	NULL
and	NULL
B	NULL
)	NULL
.	NULL

Most	NULL
normal	NULL
mature	NULL
murine	NULL
neutrophils	NULL
exhibit	NULL
ring-form	NULL
nuclei	NULL
with	NULL
nuclear	NULL
appendages	NULL
and	NULL
condensed	NULL
chromatin	NULL
(	NULL
34	NULL
)	NULL
.	NULL

The	NULL
chromatin	NULL
of	NULL
the	NULL
transgenic	NULL
neutrophils	NULL
was	NULL
smoother	NULL
than	NULL
that	NULL
of	NULL
control	NULL
cells	NULL
and	NULL
nuclear	NULL
appendages	NULL
were	NULL
less	NULL
frequent	NULL
.	NULL

More	NULL
than	NULL
100	NULL
transgenic	NULL
mice	NULL
were	NULL
observed	NULL
for	NULL
more	NULL
than	NULL
15	NULL
months	NULL
.	NULL

During	NULL
this	NULL
time	NULL
a	NULL
few	NULL
sporadic	NULL
malignancies	NULL
arose	NULL
.	NULL

Because	NULL
these	NULL
malignancies	NULL
were	NULL
rare	NULL
and	NULL
only	NULL
one	NULL
was	NULL
myeloid	NULL
,	NULL
they	NULL
could	NULL
not	NULL
be	NULL
attributed	NULL
to	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
transgene	NULL
.	NULL

PEBP2BMYH11	NULL
Transgenic	NULL
Mice	NULL
Exhibit	NULL
Alterations	NULL
in	NULL
Neutrophilic	NULL
Differentiation	NULL
in	NULL
Vivo	NULL
.	NULL

Morphologic	NULL
examination	NULL
of	NULL
the	NULL
bone	NULL
marrows	NULL
of	NULL
control	NULL
and	NULL
transgenic	NULL
mice	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
95	NULL
(	NULL
1998	NULL
)	NULL
-	NULL
11865	NULL
revealed	NULL
a	NULL
relative	NULL
increase	NULL
in	NULL
immature	NULL
neutrophilic	NULL
cells	NULL
in	NULL
transgenic	NULL
samples	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
E	NULL
and	NULL
F	NULL
and	NULL
Fig	NULL
.	NULL

34	NULL
)	NULL
.	NULL

This	NULL
shift	NULL
resulted	NULL
in	NULL
a	NULL
significant	NULL
difference	NULL
in	NULL
the	NULL
ratios	NULL
of	NULL
mature	NULL
to	NULL
immature	NULL
neutrophilic	NULL
cells	NULL
in	NULL
transgenic	NULL
as	NULL
compared	NULL
with	NULL
control	NULL
mice	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
,	NULL
Inset	NULL
)	NULL
.	NULL

The	NULL
morphology	NULL
of	NULL
the	NULL
transgenic	NULL
neutrophilic	NULL
cells	NULL
was	NULL
different	NULL
from	NULL
that	NULL
of	NULL
control	NULL
cells	NULL
,	NULL
and	NULL
we	NULL
speculated	NULL
that	NULL
the	NULL
PEBP2BMYH11	NULL
transgene	NULL
might	NULL
be	NULL
affecting	NULL
neutrophilic	NULL
maturation	NULL
in	NULL
additional	NULL
ways	NULL
that	NULL
were	NULL
not	NULL
visually	NULL
apparent	NULL
.	NULL

Because	NULL
the	NULL
buoyant	NULL
density	NULL
of	NULL
normal	NULL
neutrophils	NULL
increases	NULL
as	NULL
they	NULL
accumulate	NULL
secondary	NULL
granules	NULL
and	NULL
mature	NULL
,	NULL
we	NULL
compared	NULL
the	NULL
density	NULL
of	NULL
bone	NULL
marrow	NULL
neutrophilic	NULL
cells	NULL
of	NULL
control	NULL
and	NULL
transgenic	NULL
mice	NULL
.	NULL

Bone	NULL
marrows	NULL
were	NULL
analyzed	NULL
by	NULL
using	NULL
a	NULL
two-step	NULL
Percoll	NULL
density	NULL
gradient	NULL
.	NULL

In	NULL
this	NULL
assay	NULL
,	NULL
erythroid	NULL
,	NULL
lymphoid	NULL
,	NULL
and	NULL
early	NULL
myeloid	NULL
cells	NULL
of	NULL
normal	NULL
bone	NULL
marrow	NULL
sediment	NULL
in	NULL
a	NULL
lower	NULL
density	NULL
fraction	NULL
,	NULL
whereas	NULL
most	NULL
maturing	NULL
neutrophilic	NULL
cells	NULL
sediment	NULL
in	NULL
a	NULL
higher	NULL
density	NULL
fraction	NULL
.	NULL

In	NULL
the	NULL
PEBP2BMYH11	NULL
transgenics	NULL
there	NULL
was	NULL
a	NULL
conspicuous	NULL
decrease	NULL
in	NULL
the	NULL
density	NULL
of	NULL
maturing	NULL
neutrophilic	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

The	NULL
decrease	NULL
in	NULL
density	NULL
was	NULL
more	NULL
pronounced	NULL
in	NULL
transgenic	NULL
line	NULL
Tg237	NULL
than	NULL
in	NULL
line	NULL
Tg259	NULL
,	NULL
corresponding	NULL
with	NULL
the	NULL
relative	NULL
levels	NULL
of	NULL
transgene	NULL
expression	NULL
.	NULL

Pebp2	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
regulate	NULL
transcription	NULL
of	NULL
the	NULL
neutrophil	NULL
myeloperoxidase	NULL
gene	NULL
(	NULL
35	NULL
)	NULL
.	NULL

Although	NULL
we	NULL
have	NULL
not	NULL
rigorously	NULL
quantified	NULL
levels	NULL
of	NULL
myeloperoxidase	NULL
in	NULL
neutrophils	NULL
of	NULL
transgenic	NULL
mice	NULL
,	NULL
the	NULL
results	NULL
obtained	NULL
with	NULL
a	NULL
Technicon	NULL
H-3	NULL
automated	NULL
cell	NULL
counter	NULL
showed	NULL
that	NULL
myeloperoxidase	NULL
was	NULL
present	NULL
in	NULL
peripheral	NULL
blood	NULL
neutrophils	NULL
of	NULL
the	NULL
transgenic	NULL
mice	NULL
and	NULL
that	NULL
the	NULL
level	NULL
of	NULL
expression	NULL
was	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
control	NULL
neutrophils	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
PEBP2BMYH11	NULL
Transgene	NULL
Inhibits	NULL
Neutrophilic	NULL
Differentiation	NULL
in	NULL
Vitro	NULL
.	NULL

Although	NULL
the	NULL
PEBP2BMYH11	NULL
transgenic	NULL
animals	NULL
were	NULL
able	NULL
to	NULL
maintain	NULL
normal	NULL
peripheral	NULL
blood	NULL
neutrophil	NULL
numbers	NULL
,	NULL
we	NULL
examined	NULL
whether	NULL
the	NULL
transgene	NULL
could	NULL
exert	NULL
more	NULL
severe	NULL
effects	NULL
in	NULL
vitro	NULL
.	NULL

Bone	NULL
marrow	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
semi-solid	NULL
methylcellulose	NULL
medium	NULL
supplemented	NULL
with	NULL
growth	NULL
factors	NULL
.	NULL

Initially	NULL
,	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
a	NULL
mix	NULL
of	NULL
cytokines	NULL
provided	NULL
by	NULL
pokeweed	NULL
mitogen	NULL
spleen	NULL
conditioned	NULL
media	NULL
.	NULL

The	NULL
numbers	NULL
of	NULL
colonies	NULL
present	NULL
in	NULL
transgenic	NULL
cultures	NULL
did	NULL
not	NULL
differ	NULL
from	NULL
those	NULL
of	NULL
control	NULL
cultures	NULL
(	NULL
control	NULL
89	NULL
+	NULL
10	NULL
,	NULL
n	NULL
=	NULL
3	NULL
;	NULL
Tg237	NULL
90	NULL
+	NULL
8	NULL
,	NULL
n	NULL
=	NULL
3	NULL
)	NULL
but	NULL
when	NULL
cells	NULL
harvested	NULL
from	NULL
the	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Aberrant	NULL
neutrophilic	NULL
maturation	NULL
in	NULL
PEBP26MYH11	NULL
transgenic	NULL
mice	NULL
.	NULL

(	NULL
4	NULL
and	NULL
£	NULL
)	NULL
Samples	NULL
from	NULL
control	NULL
mice	NULL
.	NULL

(	NULL
B	NULL
and	NULL
F	NULL
)	NULL
Samples	NULL
from	NULL
PEBP2GMYH11	NULL
transgenic	NULL
mice	NULL
(	NULL
line	NULL
Tg237	NULL
)	NULL
.	NULL

(	NULL
C	NULL
and	NULL
G	NULL
)	NULL
Samples	NULL
from	NULL
transgenic	NULL
mice	NULL
(	NULL
line	NULL
Tg7	NULL
)	NULL
.	NULL

(	NULL
D	NULL
and	NULL
H	NULL
)	NULL
Samples	NULL
from	NULL
PEBP2BMYH11/NRASS	NULL
``	NULL
double	NULL
transgenic	NULL
mice	NULL
.	NULL

(	NULL
4-D	NULL
)	NULL
Peripheral	NULL
blood	NULL
neutrophils	NULL
.	NULL

(	NULL
E-H	NULL
)	NULL
Bone	NULL
marrow	NULL
.	NULL

(	NULL
Original	NULL
magnification	NULL
,	NULL
X250	NULL
.	NULL
)	NULL

11866	NULL
_	NULL
Medical	NULL
Sciences	NULL
:	NULL
Kogan	NULL
et	NULL
al	NULL
.	NULL

2	NULL
.	NULL

144	NULL
$	NULL
124	NULL
B	NULL
©	NULL
&	NULL
&	NULL
in	NULL
@	NULL
®	NULL
£08	NULL
404	NULL
©	NULL
o4	NULL
]	NULL
D	NULL
Control	NULL
70	NULL
5.	NULL
o4	NULL
L	NULL
Tgaso	NULL
60	NULL
0	NULL
.	NULL

MatureAmmature	NULL
Neut	NULL
R	NULL
tsas	NULL
50	NULL
&	NULL
~	NULL
om	NULL
m	NULL
om	NULL
oce	NULL
an	NULL
Pa	NULL
0	NULL
SUI	NULL
9	NULL
6	NULL
«	NULL
n	NULL
aa	NULL
o	NULL
Percentage	NULL
of	NULL
Nucleated	NULL
Cells	NULL
Percentage	NULL
of	NULL
Total	NULL
Neutrophilic	NULL
Cells	NULL
m	NULL
o	NULL
o	NULL
a	NULL
Neutrophilic	NULL
Cells	NULL
in	NULL
Higher	NULL
Density	NULL
Fraction	NULL
o	NULL
Immature	NULL
-	NULL
Mature	NULL
-	NULL
Eryth	NULL
Neut	NULL
Neut	NULL
Lymph	NULL
-	NULL
Eosin	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

(	NULL
4	NULL
)	NULL
Bone	NULL
marrow	NULL
differential	NULL
cell	NULL
counts	NULL
.	NULL

Differential	NULL
cell	NULL
counts	NULL
(	NULL
total	NULL
of	NULL
400	NULL
cells	NULL
each	NULL
)	NULL
were	NULL
performed	NULL
on	NULL
bone	NULL
marrow	NULL
smears	NULL
.	NULL

Data	NULL
are	NULL
shown	NULL
as	NULL
arithmetic	NULL
means	NULL
+	NULL
SD	NULL
.	NULL

Pro	NULL
,	NULL
promyelo-cytes	NULL
;	NULL
Immature	NULL
Neut	NULL
,	NULL
neutrophilic	NULL
myelocytes	NULL
and	NULL
metamyelocytes	NULL
;	NULL
Mature	NULL
Neut	NULL
,	NULL
neutrophilic	NULL
band	NULL
,	NULL
mature	NULL
ring	NULL
,	NULL
and	NULL
polymorphonuclear	NULL
forms	NULL
;	NULL
Eryth	NULL
,	NULL
nucleated	NULL
erythroid	NULL
cells	NULL
;	NULL
Lymph	NULL
,	NULL
lymphocytes	NULL
;	NULL
Eosin	NULL
,	NULL
eosinophilic	NULL
cells	NULL
.	NULL

Control	NULL
,	NULL
»	NULL
=	NULL
6	NULL
;	NULL
Tg259	NULL
,	NULL
n	NULL
=	NULL
6	NULL
;	NULL
Tg237	NULL
,	NULL
n	NULL
=	NULL
6	NULL
.	NULL

(	NULL
Inset	NULL
)	NULL
Ratios	NULL
of	NULL
mature	NULL
to	NULL
immature	NULL
neutrophilic	NULL
cells	NULL
.	NULL

*	NULL
indicates	NULL
a	NULL
significant	NULL
shift	NULL
toward	NULL
immature	NULL
cells	NULL
is	NULL
present	NULL
in	NULL
the	NULL
bone	NULL
marrow	NULL
of	NULL
the	NULL
transgenic	NULL
mice	NULL
,	NULL
P	NULL
=	NULL
0.004	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Density	NULL
of	NULL
bone	NULL
marrow	NULL
neutrophilic	NULL
cells	NULL
.	NULL

Bone	NULL
marrow	NULL
cells	NULL
were	NULL
separated	NULL
into	NULL
low	NULL
and	NULL
high	NULL
density	NULL
fractions	NULL
on	NULL
a	NULL
Percoll	NULL
step	NULL
gradient	NULL
.	NULL

Total	NULL
numbers	NULL
of	NULL
cells	NULL
present	NULL
in	NULL
each	NULL
fraction	NULL
were	NULL
determined	NULL
.	NULL

Differential	NULL
cell	NULL
counts	NULL
(	NULL
total	NULL
of	NULL
100	NULL
cells	NULL
each	NULL
)	NULL
were	NULL
performed	NULL
on	NULL
cytospins	NULL
of	NULL
each	NULL
fraction	NULL
,	NULL
with	NULL
cells	NULL
morphologically	NULL
identified	NULL
as	NULL
neutrophilic	NULL
(	NULL
neutrophilic	NULL
myelocytes	NULL
,	NULL
metamyelocytes	NULL
,	NULL
ring	NULL
,	NULL
band	NULL
,	NULL
and	NULL
polymorphonuclear	NULL
forms	NULL
)	NULL
or	NULL
non-neutrophilic	NULL
.	NULL

Total	NULL
cell	NULL
counts	NULL
and	NULL
differential	NULL
counts	NULL
were	NULL
used	NULL
to	NULL
calculate	NULL
the	NULL
mean	NULL
percentages	NULL
of	NULL
neutrophilic	NULL
cells	NULL
present	NULL
in	NULL
the	NULL
high	NULL
density	NULL
fractions	NULL
.	NULL

Data	NULL
are	NULL
shown	NULL
as	NULL
arithmetic	NULL
means	NULL
+	NULL
SD	NULL
.	NULL

Control	NULL
,	NULL
n	NULL
=	NULL
7	NULL
,	NULL
Tg259	NULL
,	NULL
n	NULL
=	NULL
5	NULL
;	NULL
Tg237	NULL
,	NULL
n	NULL
=	NULL
6.	NULL
t	NULL
,	NULL
Control	NULL
vs.	NULL
Tg259	NULL
,	NULL
P	NULL
=	NULL
0.0006	NULL
.	NULL

£	NULL
,	NULL
Control	NULL
vs.	NULL
Tg237	NULL
,	NULL
P	NULL
=	NULL
0.00002	NULL
;	NULL
Tg259	NULL
vs.	NULL
Tg237	NULL
,	NULL
P	NULL
=	NULL
0.002.	NULL
semi-solid	NULL
cultures	NULL
were	NULL
analyzed	NULL
there	NULL
was	NULL
a	NULL
decrease	NULL
in	NULL
the	NULL
generation	NULL
of	NULL
neutrophilic	NULL
cells	NULL
.	NULL

By	NULL
morphologic	NULL
examination	NULL
fewer	NULL
neutrophils	NULL
were	NULL
present	NULL
in	NULL
cultures	NULL
of	NULL
line	NULL
Tg237	NULL
bone	NULL
marrow	NULL
than	NULL
cultures	NULL
of	NULL
control	NULL
bone	NULL
marrow	NULL
(	NULL
control	NULL
11	NULL
%	NULL
*	NULL
3	NULL
%	NULL
,	NULL
Tg237	NULL
3	NULL
%	NULL
+	NULL
0.2	NULL
%	NULL
,	NULL
P	NULL
=	NULL
0.04	NULL
)	NULL
.	NULL

To	NULL
further	NULL
examine	NULL
the	NULL
effect	NULL
of	NULL
PEBP2BMYH11	NULL
on	NULL
neutrophil	NULL
differentiation	NULL
in	NULL
vitro	NULL
,	NULL
bone	NULL
marrow	NULL
of	NULL
control	NULL
and	NULL
transgenic	NULL
mice	NULL
was	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
G-CSF	NULL
or	NULL
GM-CSF	NULL
;	NULL
these	NULL
conditions	NULL
relatively	NULL
enhanced	NULL
the	NULL
generation	NULL
of	NULL
neutrophils	NULL
.	NULL

Although	NULL
numerous	NULL
macrophages	NULL
were	NULL
present	NULL
in	NULL
all	NULL
cultures	NULL
,	NULL
fewer	NULL
neutrophils	NULL
were	NULL
observed	NULL
in	NULL
cultures	NULL
of	NULL
transgenic	NULL
bone	NULL
marrow	NULL
than	NULL
in	NULL
cultures	NULL
of	NULL
control	NULL
bone	NULL
marrow	NULL
(	NULL
Table	NULL
1	NULL
,	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

The	NULL
differences	NULL
in	NULL
relative	NULL
and	NULL
absolute	NULL
neutrophil	NULL
numbers	NULL
were	NULL
statistically	NULL
significant	NULL
and	NULL
the	NULL
magnitude	NULL
of	NULL
inhibition	NULL
corresponded	NULL
with	NULL
the	NULL
level	NULL
of	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
95	NULL
(	NULL
1998	NULL
)	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Morphology	NULL
of	NULL
bone	NULL
marrow	NULL
cells	NULL
cultured	NULL
in	NULL
vitro	NULL
.	NULL

Bone	NULL
marrow	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
semisolid	NULL
methylcellulose	NULL
medium	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
G-CSF	NULL
at	NULL
2.5	NULL
X	NULL
10°	NULL
cells/ml	NULL
for	NULL
7	NULL
days	NULL
,	NULL
and	NULL
cytospins	NULL
of	NULL
harvested	NULL
cells	NULL
were	NULL
prepared	NULL
.	NULL

Numerous	NULL
macrophages	NULL
(	NULL
arrow	NULL
)	NULL
and	NULL
neutrophilic	NULL
cells	NULL
(	NULL
arrowhead	NULL
)	NULL
were	NULL
observed	NULL
in	NULL
the	NULL
control	NULL
samples	NULL
.	NULL

Neutrophilic	NULL
cells	NULL
were	NULL
decreased	NULL
in	NULL
the	NULL
samples	NULL
from	NULL
transgenic	NULL
mice	NULL
.	NULL

(	NULL
Insets	NULL
)	NULL
Neutrophil	NULL
morphology	NULL
.	NULL

Neutrophils	NULL
derived	NULL
in	NULL
vitro	NULL
from	NULL
the	NULL
bone	NULL
marrows	NULL
of	NULL
transgenic	NULL
mice	NULL
exhibited	NULL
atypical	NULL
morphology	NULL
.	NULL

(	NULL
Original	NULL
magnification	NULL
,	NULL
X250	NULL
.	NULL
)	NULL

transgene	NULL
expression	NULL
.	NULL

Of	NULL
note	NULL
,	NULL
neutrophils	NULL
decreased	NULL
despite	NULL
a	NULL
trend	NULL
toward	NULL
larger	NULL
numbers	NULL
of	NULL
colony-forming	NULL
units	NULL
in	NULL
the	NULL
transgenic	NULL
animals	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
a	NULL
quantitative	NULL
effect	NULL
on	NULL
neutrophil	NULL
generation	NULL
,	NULL
qualitative	NULL
differences	NULL
were	NULL
observed	NULL
:	NULL
neutrophilic	NULL
cells	NULL
that	NULL
did	NULL
appear	NULL
in	NULL
the	NULL
transgenic	NULL
cultures	NULL
were	NULL
more	NULL
likely	NULL
to	NULL
display	NULL
immature	NULL
or	NULL
atypical	NULL
nuclear	NULL
morphology	NULL
and	NULL
to	NULL
have	NULL
cytoplasmic	NULL
vacuoles	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
Insets	NULL
)	NULL
.	NULL

PEBP2BMYH11	NULL
Cooperates	NULL
with	NULL
Activated	NULL
NRAS	NULL
to	NULL
Foster	NULL
Aberrant	NULL
Neutrophilic	NULL
Maturation	NULL
.	NULL

Activating	NULL
mutations	NULL
of	NULL
the	NULL
RAS	NULL
protooncogenes	NULL
are	NULL
common	NULL
in	NULL
myelodysplasia	NULL
and	NULL
acute	NULL
myeloid	NULL
leukemia	NULL
(	NULL
36	NULL
)	NULL
.	NULL

This	NULL
observation	NULL
and	NULL
a	NULL
previous	NULL
report	NULL
showing	NULL
that	NULL
the	NULL
bone	NULL
marrow	NULL
of	NULL
some	NULL
patients	NULL
with	NULL
inv	NULL
(	NULL
16	NULL
)	NULL
contained	NULL
RAS	NULL
mutations	NULL
(	NULL
37	NULL
)	NULL
suggested	NULL
that	NULL
these	NULL
molecular	NULL
alterations	NULL
might	NULL
cooperate	NULL
in	NULL
leukemogenesis	NULL
.	NULL

To	NULL
test	NULL
this	NULL
hypothesis	NULL
,	NULL
we	NULL
crossed	NULL
the	NULL
PEBP2BMYH11	NULL
transgenic	NULL
Table	NULL
1	NULL
.	NULL

Methylcellulose	NULL
cultures	NULL
Neutrophils	NULL
,	NULL
Colonies	NULL
Neutrophils	NULL
,	NULL
%	NULL
xX	NULL
10+/ml	NULL
G-CSF	NULL
Control	NULL
ND	NULL
36	NULL
+	NULL
9.0	NULL
8.0	NULL
+	NULL
6.4	NULL
Tg259	NULL
ND	NULL
17	NULL
+	NULL
1.5	NULL
,	NULL
P	NULL
=	NULL
0.07	NULL
5.2	NULL
+	NULL
1.4	NULL
,	NULL
P	NULL
=	NULL
0.48	NULL
Tg237	NULL
ND	NULL
6	NULL
+	NULL
2.0	NULL
,	NULL
P	NULL
=	NULL
0.03	NULL
1.5	NULL
+	NULL
0.5	NULL
,	NULL
P	NULL
=	NULL
0.19	NULL
G-CSF	NULL
Control	NULL
32.7	NULL
+	NULL
8.0	NULL
39.5	NULL
+	NULL
6.1	NULL
0.8	NULL
+	NULL
0.1	NULL
Tg259	NULL
45.7	NULL
+	NULL
2.1	NULL
,	NULL
P	NULL
=	NULL
0.10	NULL
25.5	NULL
+	NULL
0.5	NULL
,	NULL
P	NULL
=	NULL
0.06	NULL
0.5	NULL
+	NULL
0.1	NULL
,	NULL
P	NULL
=	NULL
0.05	NULL
Tg237	NULL
44.3	NULL
+	NULL
7.0	NULL
,	NULL
P	NULL
=	NULL
0.13	NULL
6.3	NULL
+	NULL
1.7	NULL
,	NULL
P	NULL
=	NULL
0.008	NULL
0.1	NULL
+	NULL
0.04	NULL
,	NULL
P	NULL
=	NULL
0.008	NULL
GM-CSF	NULL
Control	NULL
87	NULL
+	NULL
8.9	NULL
37.7	NULL
+	NULL
5.1	NULL
9.0	NULL
+	NULL
0.9	NULL
Tg259	NULL
119	NULL
+	NULL
11.6	NULL
,	NULL
P	NULL
=	NULL
0.02	NULL
21.3	NULL
+	NULL
5.0	NULL
,	NULL
P	NULL
=	NULL
0.02	NULL
5.0	NULL
+	NULL
0.8	NULL
,	NULL
P	NULL
=	NULL
0.005	NULL
Tg237	NULL
114	NULL
+	NULL
19.7	NULL
,	NULL
P	NULL
=	NULL
0.13	NULL
9.8	NULL
+	NULL
2.0	NULL
,	NULL
P	NULL
=	NULL
0.005	NULL
2.2	NULL
+	NULL
0.8	NULL
,	NULL
P	NULL
=	NULL
0.0006	NULL
Data	NULL
were	NULL
derived	NULL
from	NULL
independent	NULL
experiments	NULL
a	NULL
and	NULL
b	NULL
.	NULL

Data	NULL
were	NULL
derived	NULL
from	NULL
results	NULL
with	NULL
three	NULL
mice	NULL
in	NULL
each	NULL
group	NULL
in	NULL
each	NULL
experiment	NULL
.	NULL

P	NULL
values	NULL
,	NULL
transgenic	NULL
mice	NULL
compared	NULL
to	NULL
control	NULL
mice	NULL
.	NULL

ND	NULL
,	NULL
not	NULL
determined	NULL
.	NULL

4Cells	NULL
were	NULL
plated	NULL
at	NULL
2.5	NULL
X	NULL
10	NULL
%	NULL
/ml	NULL
.	NULL

Cells	NULL
were	NULL
plated	NULL
at	NULL
5.0	NULL
x	NULL
10+/ml	NULL
.	NULL

Medical	NULL
Sciences	NULL
:	NULL
Kogan	NULL
et	NULL
al	NULL
.	NULL

mice	NULL
with	NULL
FVB/N	NULL
transgenic	NULL
mice	NULL
generated	NULL
in	NULL
our	NULL
laboratory	NULL
that	NULL
expressed	NULL
activated	NULL
NRAS	NULL
(	NULL
NRAS	NULL
``	NULL
2	NULL
``	NULL
)	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
hMRPS8	NULL
promoter	NULL
.	NULL

Our	NULL
transgenic	NULL
mice	NULL
overexpressed	NULL
NRas	NULL
in	NULL
their	NULL
bone	NULL
marrow	NULL
as	NULL
assessed	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
with	NULL
an	NULL
anti-NRas	NULL
antiserum	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

There	NULL
was	NULL
a	NULL
relative	NULL
increase	NULL
in	NULL
immature	NULL
neutrophilic	NULL
cells	NULL
in	NULL
the	NULL
bone	NULL
marrow	NULL
of	NULL
these	NULL
transgenics	NULL
,	NULL
and	NULL
the	NULL
morphology	NULL
of	NULL
these	NULL
cells	NULL
was	NULL
slightly	NULL
atypical	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
C	NULL
and	NULL
G	NULL
)	NULL
,	NULL
but	NULL
the	NULL
mice	NULL
did	NULL
not	NULL
develop	NULL
acute	NULL
myeloid	NULL
leukemia	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
presumably	NULL
because	NULL
of	NULL
transgene	NULL
expression	NULL
in	NULL
the	NULL
epidermis	NULL
,	NULL
the	NULL
NRAS	NULL
``	NULL
``	NULL
transgenic	NULL
mice	NULL
developed	NULL
abnormal	NULL
hyperkeratotic	NULL
skin	NULL
lesions	NULL
.	NULL

Hyperkeratotic	NULL
skin	NULL
often	NULL
became	NULL
secondarily	NULL
infected	NULL
with	NULL
fecal	NULL
flora	NULL
and	NULL
thereby	NULL
promoted	NULL
an	NULL
intense	NULL
reactive	NULL
proliferation	NULL
of	NULL
myeloid	NULL
cells	NULL
,	NULL
especially	NULL
in	NULL
the	NULL
line	NULL
of	NULL
NRAS	NULL
``	NULL
``	NULL
``	NULL
transgenic	NULL
mice	NULL
that	NULL
expressed	NULL
the	NULL
highest	NULL
level	NULL
of	NULL
activated	NULL
Ras	NULL
protein	NULL
,	NULL
line	NULL
Tg	NULL
?	NULL

7	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

When	NULL
the	NULL
Tg7	NULL
NRAS	NULL
``	NULL
2	NULL
``	NULL
transgene	NULL
was	NULL
combined	NULL
with	NULL
the	NULL
Tg237	NULL
PEBP2BMYH1I1	NULL
transgene	NULL
,	NULL
neutrophilic	NULL
cells	NULL
of	NULL
the	NULL
doubly	NULL
transgenic	NULL
mice	NULL
exhibited	NULL
markedly	NULL
aberrant	NULL
morphology	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
D	NULL
and	NULL
H	NULL
)	NULL
.	NULL

In	NULL
normal	NULL
murine	NULL
bone	NULL
marrow	NULL
,	NULL
most	NULL
immature	NULL
neutrophils	NULL
have	NULL
ring-shaped	NULL
nuclei	NULL
(	NULL
34	NULL
)	NULL
and	NULL
the	NULL
nuclei	NULL
of	NULL
mature	NULL
neutrophils	NULL
display	NULL
condensed	NULL
chromatin	NULL
with	NULL
complex	NULL
twisted	NULL
shapes	NULL
.	NULL

Band-form	NULL
,	NULL
bi-lobed	NULL
,	NULL
and	NULL
multi-lobed	NULL
nuclei	NULL
are	NULL
unusual	NULL
.	NULL

In	NULL
doubly	NULL
transgenic	NULL
bone	NULL
marrow	NULL
,	NULL
numerous	NULL
immature	NULL
neutrophils	NULL
had	NULL
band-form	NULL
nuclei	NULL
and	NULL
mature	NULL
nuclei	NULL
displayed	NULL
abnormally	NULL
smooth	NULL
chromatin	NULL
.	NULL

Bi-lobed	NULL
neutrophils	NULL
were	NULL
common	NULL
,	NULL
and	NULL
nuclei	NULL
with	NULL
multiple	NULL
segments	NULL
were	NULL
seen	NULL
.	NULL

The	NULL
abnormalities	NULL
observed	NULL
were	NULL
reminiscent	NULL
of	NULL
those	NULL
seen	NULL
in	NULL
the	NULL
human	NULL
myelodysplastic	NULL
syndromes	NULL
and	NULL
may	NULL
represent	NULL
a	NULL
murine	NULL
version	NULL
of	NULL
dysgranulopoiesis	NULL
.	NULL

PEBP2BMYH11	NULL
transgenic	NULL
mice	NULL
did	NULL
not	NULL
themselves	NULL
exhibit	NULL
skin	NULL
abnormalities	NULL
.	NULL

However	NULL
,	NULL
the	NULL
skin	NULL
lesions	NULL
that	NULL
developed	NULL
in	NULL
the	NULL
doubly	NULL
transgenic	NULL
animals	NULL
interfered	NULL
with	NULL
analysis	NULL
of	NULL
the	NULL
combined	NULL
effects	NULL
of	NULL
the	NULL
transgenes	NULL
on	NULL
the	NULL
hematopoietic	NULL
system	NULL
by	NULL
stimulating	NULL
myeloid	NULL
hyperplasia	NULL
and	NULL
by	NULL
limiting	NULL
the	NULL
lifespans	NULL
of	NULL
the	NULL
mice	NULL
.	NULL

To	NULL
assess	NULL
the	NULL
impact	NULL
of	NULL
the	NULL
combination	NULL
of	NULL
PEBP2BMYH11	NULL
and	NULL
NRAS	NULL
``	NULL
``	NULL
``	NULL
transgenes	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
skin	NULL
lesions	NULL
,	NULL
we	NULL
transplanted	NULL
doubly	NULL
transgenic	NULL
bone	NULL
marrow	NULL
into	NULL
lethally	NULL
irradiated	NULL
nontransgenic	NULL
FVB/N	NULL
mice	NULL
.	NULL

None	NULL
of	NULL
the	NULL
28	NULL
recipients	NULL
of	NULL
doubly	NULL
transgenic	NULL
bone	NULL
marrow	NULL
developed	NULL
acute	NULL
leukemia	NULL
over	NULL
the	NULL
course	NULL
of	NULL
15	NULL
months	NULL
.	NULL

The	NULL
bone	NULL
marrow	NULL
of	NULL
11	NULL
mice	NULL
reconstituted	NULL
with	NULL
doubly	NULL
transgenic	NULL
cells	NULL
was	NULL
examined	NULL
morphologically	NULL
.	NULL

Similar	NULL
to	NULL
what	NULL
we	NULL
observed	NULL
in	NULL
nontransplanted	NULL
doubly	NULL
transgenic	NULL
animals	NULL
,	NULL
these	NULL
bone	NULL
marrow	NULL
displayed	NULL
a	NULL
relative	NULL
increase	NULL
in	NULL
immature	NULL
neutrophilic	NULL
cells	NULL
and	NULL
aberrant	NULL
neutrophilic	NULL
differentiation	NULL
.	NULL

The	NULL
percentage	NULL
of	NULL
total	NULL
mature	NULL
neutrophils	NULL
with	NULL
dysplastic	NULL
morphology	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
for	NULL
definitions	NULL
)	NULL
was	NULL
increased	NULL
significantly	NULL
in	NULL
the	NULL
recipients	NULL
of	NULL
doubly	NULL
transgenic	NULL
bone	NULL
marrow	NULL
when	NULL
compared	NULL
with	NULL
recipients	NULL
of	NULL
control	NULL
bone	NULL
marrow	NULL
(	NULL
control	NULL
4.0	NULL
+	NULL
1.4	NULL
%	NULL
,	NULL
n	NULL
=	NULL
4	NULL
;	NULL
doubly	NULL
trangenic	NULL
mice	NULL
79	NULL
+	NULL
15	NULL
%	NULL
,	NULL
n	NULL
=	NULL
11	NULL
;	NULL
P	NULL
<	NULL
0.00001	NULL
)	NULL
.	NULL

Neutrophil	NULL
dysplasia	NULL
was	NULL
also	NULL
more	NULL
prominent	NULL
when	NULL
the	NULL
doubly	NULL
transgenic	NULL
mice	NULL
were	NULL
compared	NULL
with	NULL
mice	NULL
carrying	NULL
single	NULL
transgenes	NULL
(	NULL
Tg237	NULL
11	NULL
+	NULL
2.7	NULL
%	NULL
,	NULL
n	NULL
=	NULL
4	NULL
,	NULL
P	NULL
<	NULL
0.00001	NULL
;	NULL
Tg7	NULL
16.5	NULL
+	NULL
8.4	NULL
%	NULL
,	NULL
P	NULL
<	NULL
0.00001	NULL
)	NULL
.	NULL

DISCUSSION	NULL
Pebp2Smmhe	NULL
Impairs	NULL
but	NULL
Does	NULL
Not	NULL
Block	NULL
Neutrophilic	NULL
Differentiation	NULL
.	NULL

By	NULL
expressing	NULL
Pebp2BSmmhe	NULL
in	NULL
myeloid	NULL
cells	NULL
of	NULL
transgenic	NULL
mice	NULL
we	NULL
have	NULL
demonstrated	NULL
that	NULL
this	NULL
leukemia-associated	NULL
chimeric	NULL
protein	NULL
impairs	NULL
but	NULL
does	NULL
not	NULL
block	NULL
neutrophil	NULL
development	NULL
.	NULL

The	NULL
PEBP2BMYH1T1	NULL
transgenic	NULL
mice	NULL
maintained	NULL
normal	NULL
numbers	NULL
of	NULL
circulating	NULL
neutrophils	NULL
.	NULL

Immature	NULL
neutrophilic	NULL
cells	NULL
were	NULL
increased	NULL
in	NULL
the	NULL
bone	NULL
marrow	NULL
of	NULL
transgenic	NULL
animals	NULL
,	NULL
and	NULL
those	NULL
cells	NULL
exhibited	NULL
qualitative	NULL
abnormalities	NULL
.	NULL

In	NULL
vitro	NULL
,	NULL
a	NULL
decrease	NULL
in	NULL
the	NULL
generation	NULL
of	NULL
neutrophils	NULL
from	NULL
transgenic	NULL
bone	NULL
marrow	NULL
was	NULL
observed	NULL
in	NULL
methylcellulose	NULL
cultures	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
95	NULL
(	NULL
1998	NULL
)	NULL
-	NULL
11867	NULL
The	NULL
effects	NULL
of	NULL
the	NULL
transgene	NULL
on	NULL
neutrophil	NULL
differentiation	NULL
depended	NULL
on	NULL
conditions	NULL
.	NULL

Although	NULL
moderate	NULL
effects	NULL
of	NULL
Pebp2BSmmhe	NULL
were	NULL
seen	NULL
under	NULL
baseline	NULL
conditions	NULL
in	NULL
transgenic	NULL
mice	NULL
,	NULL
marked	NULL
effects	NULL
were	NULL
observed	NULL
in	NULL
colony	NULL
assays	NULL
,	NULL
and	NULL
the	NULL
in	NULL
vivo	NULL
effects	NULL
of	NULL
the	NULL
chimeric	NULL
protein	NULL
were	NULL
enhanced	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
activated	NULL
Ras	NULL
.	NULL

Another	NULL
demonstration	NULL
that	NULL
the	NULL
effects	NULL
of	NULL
Pebp2	NULL
$	NULL
Smmhe	NULL
on	NULL
neutrophil	NULL
differentiation	NULL
are	NULL
context	NULL
dependent	NULL
is	NULL
provided	NULL
by	NULL
comparing	NULL
our	NULL
results	NULL
with	NULL
those	NULL
obtained	NULL
by	NULL
expressing	NULL
Pebp2	NULL
$	NULL
Smmhce	NULL
in	NULL
the	NULL
32Dc13	NULL
myeloid	NULL
cell	NULL
line	NULL
.	NULL

Pebp26Smmhe	NULL
slowed	NULL
the	NULL
growth	NULL
of	NULL
32Dc13	NULL
cells	NULL
but	NULL
did	NULL
not	NULL
impair	NULL
their	NULL
ability	NULL
to	NULL
differentiate	NULL
to	NULL
neutrophils	NULL
in	NULL
G-CSF	NULL
(	NULL
32	NULL
)	NULL
.	NULL

Our	NULL
results	NULL
complement	NULL
those	NULL
obtained	NULL
by	NULL
targeting	NULL
expression	NULL
of	NULL
Pebp2BMYH11	NULL
to	NULL
the	NULL
Pebp2	NULL
$	NULL
B	NULL
locus	NULL
(	NULL
17	NULL
)	NULL
.	NULL

By	NULL
choosing	NULL
a	NULL
promoter	NULL
that	NULL
is	NULL
not	NULL
active	NULL
in	NULL
hematopoietic	NULL
stem	NULL
cells	NULL
we	NULL
have	NULL
avoided	NULL
the	NULL
embryonic	NULL
lethality	NULL
seen	NULL
in	NULL
the	NULL
previous	NULL
study	NULL
.	NULL

Perhaps	NULL
expression	NULL
of	NULL
during	NULL
the	NULL
earliest	NULL
stages	NULL
of	NULL
definitive	NULL
hematopoiesis	NULL
impairs	NULL
a	NULL
transcriptional	NULL
program	NULL
for	NULL
which	NULL
appropriate	NULL
Pebp2	NULL
activity	NULL
is	NULL
absolutely	NULL
required	NULL
.	NULL

Such	NULL
impairment	NULL
may	NULL
prevent	NULL
the	NULL
development	NULL
of	NULL
cells	NULL
normally	NULL
destined	NULL
to	NULL
form	NULL
the	NULL
definitive	NULL
hematopoietic	NULL
system	NULL
.	NULL

Additional	NULL
data	NULL
derived	NULL
from	NULL
the	NULL
Pebp2BMYH11	NULL
``	NULL
knock-in	NULL
``	NULL
mice	NULL
indicated	NULL
that	NULL
Pebp2Smmhe	NULL
impaired	NULL
but	NULL
did	NULL
not	NULL
block	NULL
the	NULL
differentiation	NULL
of	NULL
primitive	NULL
erythroid	NULL
cells	NULL
.	NULL

Our	NULL
results	NULL
extend	NULL
these	NULL
data	NULL
by	NULL
demonstrating	NULL
that	NULL
Pebp2BSmmhe	NULL
impairs	NULL
the	NULL
differentiation	NULL
of	NULL
myeloid	NULL
cells	NULL
,	NULL
leukemias	NULL
of	NULL
which	NULL
are	NULL
associated	NULL
with	NULL
Pebp2BSmmhe	NULL
expression	NULL
.	NULL

Pebp2BSmmhe	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
interfere	NULL
with	NULL
normal	NULL
Pebp2	NULL
activity	NULL
and	NULL
this	NULL
is	NULL
presumably	NULL
the	NULL
mechanism	NULL
by	NULL
which	NULL
the	NULL
chimeric	NULL
protein	NULL
exerts	NULL
its	NULL
effects	NULL
(	NULL
38	NULL
)	NULL
.	NULL

Although	NULL
Pebp26Smmhe	NULL
may	NULL
exhibit	NULL
dominant	NULL
negative	NULL
activity	NULL
(	NULL
17	NULL
)	NULL
,	NULL
the	NULL
effect	NULL
of	NULL
this	NULL
chimeric	NULL
protein	NULL
on	NULL
expression	NULL
of	NULL
Pebp2	NULL
targets	NULL
in	NULL
primary	NULL
cells	NULL
has	NULL
not	NULL
been	NULL
reported	NULL
.	NULL

We	NULL
have	NULL
observed	NULL
that	NULL
the	NULL
peripheral	NULL
blood	NULL
neutrophils	NULL
of	NULL
MRPS-PEBP2BMYH11	NULL
transgenic	NULL
mice	NULL
contain	NULL
normal	NULL
levels	NULL
of	NULL
myeloperoxidase	NULL
activity	NULL
,	NULL
the	NULL
gene	NULL
for	NULL
which	NULL
is	NULL
regulated	NULL
by	NULL
Pebp2	NULL
.	NULL

Thus	NULL
,	NULL
Pebp28Smmhe	NULL
does	NULL
not	NULL
in	NULL
this	NULL
setting	NULL
appear	NULL
to	NULL
dominantly	NULL
inhibit	NULL
Mpo	NULL
transcription	NULL
.	NULL

The	NULL
effects	NULL
of	NULL
the	NULL
protein	NULL
on	NULL
mRNA	NULL
expression	NULL
are	NULL
likely	NULL
to	NULL
be	NULL
complex	NULL
and	NULL
dependent	NULL
on	NULL
promoter	NULL
,	NULL
cell	NULL
type	NULL
,	NULL
and	NULL
the	NULL
presence	NULL
of	NULL
alterations	NULL
in	NULL
other	NULL
regulators	NULL
of	NULL
transcription	NULL
.	NULL

Of	NULL
note	NULL
,	NULL
expression	NULL
of	NULL
myeloperoxidase	NULL
in	NULL
the	NULL
32Dcl3	NULL
cell	NULL
line	NULL
was	NULL
also	NULL
unimpaired	NULL
by	NULL
Pebp2BSmmhe	NULL
(	NULL
32	NULL
)	NULL
.	NULL

We	NULL
did	NULL
not	NULL
observe	NULL
an	NULL
increase	NULL
in	NULL
eosinophils	NULL
either	NULL
in	NULL
vitro	NULL
or	NULL
in	NULL
vivo	NULL
.	NULL

The	NULL
significance	NULL
of	NULL
this	NULL
result	NULL
is	NULL
unclear	NULL
.	NULL

Not	NULL
all	NULL
leukemias	NULL
expressing	NULL
PEBP2BMYH11	NULL
exhibit	NULL
prominent	NULL
eosinophilia	NULL
(	NULL
4	NULL
)	NULL
.	NULL

However	NULL
,	NULL
our	NULL
result	NULL
may	NULL
reflect	NULL
the	NULL
fact	NULL
that	NULL
the	NULL
hMRP8	NULL
promoter	NULL
is	NULL
not	NULL
active	NULL
in	NULL
normal	NULL
eosinophils	NULL
(	NULL
EL	NULL
.	NULL

,	NULL
unpublished	NULL
data	NULL
)	NULL
.	NULL

The	NULL
fact	NULL
that	NULL
the	NULL
transgenic	NULL
mice	NULL
maintained	NULL
normal	NULL
neutrophil	NULL
numbers	NULL
points	NULL
to	NULL
the	NULL
presence	NULL
of	NULL
homeostatic	NULL
mechanisms	NULL
that	NULL
can	NULL
compensate	NULL
for	NULL
the	NULL
antidifferentiative	NULL
effects	NULL
of	NULL
Pebp2	NULL
$	NULL
Smmhe	NULL
.	NULL

These	NULL
results	NULL
are	NULL
similar	NULL
to	NULL
what	NULL
has	NULL
been	NULL
observed	NULL
in	NULL
a	NULL
number	NULL
of	NULL
studies	NULL
of	NULL
transgenic	NULL
mice	NULL
including	NULL
Eu-c-MYC	NULL
and	NULL
MRPS8-PMLRARa	NULL
transgenics	NULL
.	NULL

The	NULL
abnormal	NULL
expression	NULL
of	NULL
a	NULL
protein	NULL
associated	NULL
with	NULL
a	NULL
malignancy	NULL
of	NULL
a	NULL
particular	NULL
cell	NULL
type	NULL
can	NULL
impair	NULL
maturation	NULL
of	NULL
cells	NULL
of	NULL
that	NULL
lineage	NULL
,	NULL
but	NULL
additional	NULL
changes	NULL
are	NULL
required	NULL
to	NULL
create	NULL
the	NULL
severe	NULL
impairment	NULL
of	NULL
differentiation	NULL
that	NULL
is	NULL
characteristic	NULL
of	NULL
acute	NULL
leukemia	NULL
(	NULL
29	NULL
,	NULL
39	NULL
)	NULL
.	NULL

PEBP2BMYH11	NULL
Can	NULL
Contribute	NULL
to	NULL
Myelodysplasia	NULL
.	NULL

Alterations	NULL
of	NULL
the	NULL
PEBP2aB	NULL
and	NULL
PEBP2GB	NULL
genes	NULL
have	NULL
been	NULL
associated	NULL
with	NULL
myelodysplasia	NULL
(	NULL
8	NULL
,	NULL
40-43	NULL
)	NULL
.	NULL

Neutrophils	NULL
generated	NULL
in	NULL
vitro	NULL
from	NULL
PEBP2BMYH11	NULL
transgenic	NULL
bone	NULL
marrow	NULL
displayed	NULL
unusual	NULL
morphology	NULL
.	NULL

In	NULL
vivo	NULL
,	NULL
nuclear	NULL
and	NULL
cytoplasmic	NULL
maturation	NULL
of	NULL
neutrophils	NULL
was	NULL
impaired	NULL
,	NULL
indicative	NULL
of	NULL
dysplastic	NULL
differentiation	NULL
.	NULL

Furthermore	NULL
,	NULL
mice	NULL
that	NULL
expressed	NULL
both	NULL
PEBP2BMYH11	NULL
and	NULL
activated	NULL
RAS	NULL
transgenes	NULL
had	NULL
neutrophilic	NULL
cells	NULL
that	NULL
were	NULL
morphologically	NULL
aberrant	NULL
.	NULL

The	NULL
unusual	NULL
nuclear	NULL
morphologies	NULL
present	NULL
in	NULL
these	NULL
mice	NULL
were	NULL
reminiscent	NULL
11868	NULL
_	NULL
Medical	NULL
Sciences	NULL
:	NULL
Kogan	NULL
et	NULL
al	NULL
.	NULL

of	NULL
the	NULL
dysplastic	NULL
morphologies	NULL
seen	NULL
in	NULL
human	NULL
myelodysplasia	NULL
.	NULL

Although	NULL
we	NULL
have	NULL
not	NULL
observed	NULL
trilineage	NULL
dysplasia	NULL
in	NULL
these	NULL
mice	NULL
,	NULL
our	NULL
findings	NULL
provide	NULL
direct	NULL
evidence	NULL
that	NULL
Pebp2BSmmhe	NULL
may	NULL
contribute	NULL
to	NULL
dysplasia	NULL
by	NULL
disturbing	NULL
neutrophil	NULL
maturation	NULL
.	NULL

We	NULL
speculate	NULL
that	NULL
myelodysplasia	NULL
is	NULL
the	NULL
result	NULL
of	NULL
genetic	NULL
changes	NULL
that	NULL
impair	NULL
differentiation	NULL
in	NULL
combination	NULL
with	NULL
additional	NULL
changes	NULL
that	NULL
limit	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
bone	NULL
marrow	NULL
to	NULL
compensate	NULL
for	NULL
such	NULL
impairment	NULL
.	NULL

Our	NULL
results	NULL
contribute	NULL
to	NULL
an	NULL
understanding	NULL
of	NULL
the	NULL
abnormal	NULL
morphologies	NULL
observed	NULL
in	NULL
human	NULL
leukemia	NULL
.	NULL

The	NULL
acute	NULL
leukemias	NULL
associated	NULL
with	NULL
inv	NULL
(	NULL
16	NULL
)	NULL
can	NULL
exhibit	NULL
dysplastic	NULL
neutrophilic	NULL
cells	NULL
in	NULL
association	NULL
with	NULL
the	NULL
leukemic	NULL
blasts	NULL
.	NULL

Our	NULL
results	NULL
indicate	NULL
that	NULL
Pebp2	NULL
$	NULL
Smmhe	NULL
expression	NULL
contributes	NULL
to	NULL
this	NULL
accompanying	NULL
dysplasia	NULL
.	NULL

A	NULL
recent	NULL
report	NULL
showed	NULL
that	NULL
Pebp2aB-Eto/Aml1-Eto	NULL
also	NULL
can	NULL
contribute	NULL
to	NULL
dysplastic	NULL
differentiation	NULL
of	NULL
hematopoietic	NULL
progenitors	NULL
(	NULL
44	NULL
)	NULL
.	NULL

Although	NULL
we	NULL
expressed	NULL
the	NULL
Pebp2BSmmhe	NULL
protein	NULL
in	NULL
the	NULL
myeloid	NULL
cells	NULL
of	NULL
transgenic	NULL
mice	NULL
and	NULL
observed	NULL
a	NULL
large	NULL
number	NULL
of	NULL
these	NULL
mice	NULL
for	NULL
longer	NULL
than	NULL
1	NULL
year	NULL
,	NULL
the	NULL
mice	NULL
did	NULL
not	NULL
develop	NULL
acute	NULL
myeloid	NULL
leukemia	NULL
.	NULL

One	NULL
potential	NULL
explanation	NULL
for	NULL
the	NULL
lack	NULL
of	NULL
malignancies	NULL
is	NULL
that	NULL
we	NULL
have	NULL
not	NULL
expressed	NULL
the	NULL
protein	NULL
at	NULL
high	NULL
enough	NULL
levels	NULL
in	NULL
the	NULL
appropriate	NULL
early	NULL
myelomonocytic	NULL
progenitor	NULL
cells	NULL
.	NULL

This	NULL
possibility	NULL
can	NULL
not	NULL
be	NULL
excluded	NULL
,	NULL
despite	NULL
the	NULL
fact	NULL
that	NULL
the	NULL
transgene	NULL
appeared	NULL
to	NULL
influence	NULL
the	NULL
differentiation	NULL
of	NULL
these	NULL
progenitors	NULL
in	NULL
vitro	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
,	NULL
however	NULL
,	NULL
that	NULL
there	NULL
is	NULL
a	NULL
biological	NULL
reason	NULL
for	NULL
the	NULL
absence	NULL
of	NULL
leukemias	NULL
.	NULL

For	NULL
example	NULL
,	NULL
the	NULL
inversion	NULL
of	NULL
chromosome	NULL
16	NULL
might	NULL
not	NULL
be	NULL
the	NULL
first	NULL
event	NULL
in	NULL
leukemogenesis	NULL
but	NULL
may	NULL
instead	NULL
arise	NULL
in	NULL
cells	NULL
that	NULL
already	NULL
contain	NULL
other	NULL
genetic	NULL
abnormalities	NULL
.	NULL

Reversing	NULL
the	NULL
order	NULL
of	NULL
these	NULL
events	NULL
might	NULL
preclude	NULL
leukemogenesis	NULL
.	NULL

Our	NULL
results	NULL
provide	NULL
direct	NULL
evidence	NULL
that	NULL
genetic	NULL
alterations	NULL
of	NULL
the	NULL
Pebp2/Cbf	NULL
transcription	NULL
factor	NULL
can	NULL
contribute	NULL
to	NULL
dysplastic	NULL
changes	NULL
in	NULL
myeloid	NULL
cells	NULL
and	NULL
thereby	NULL
might	NULL
play	NULL
a	NULL
role	NULL
in	NULL
both	NULL
the	NULL
pathogenesis	NULL
of	NULL
myelodysplasia	NULL
and	NULL
in	NULL
the	NULL
dysplastic	NULL
morphologies	NULL
that	NULL
can	NULL
accompany	NULL
acute	NULL
nonlymphocytic	NULL
leukemias	NULL
.	NULL

Our	NULL
results	NULL
also	NULL
suggest	NULL
that	NULL
one	NULL
mechanism	NULL
by	NULL
which	NULL
inv	NULL
{	NULL
(	NULL
16	NULL
)	NULL
(	NULL
p13	NULL
;	NULL
q22	NULL
)	NULL
contributes	NULL
to	NULL
leukemogenesis	NULL
is	NULL
by	NULL
inhibiting	NULL
differentiation	NULL
.	NULL

We	NULL
thank	NULL
Daphne	NULL
Haas-Kogan	NULL
for	NULL
suggestions	NULL
and	NULL
support	NULL
,	NULL
Lois	NULL
Koren	NULL
and	NULL
Nadya	NULL
Milshteyn	NULL
for	NULL
technical	NULL
assistance	NULL
,	NULL
Robert	NULL
Hawley	NULL
for	NULL
the	NULL
MSCV	NULL
retroviral	NULL
vector	NULL
,	NULL
Kevin	NULL
Shannon	NULL
and	NULL
Clifford	NULL
Lowell	NULL
for	NULL
critical	NULL
reading	NULL
of	NULL
the	NULL
manuscript	NULL
,	NULL
Diane	NULL
Brown	NULL
for	NULL
discussions	NULL
and	NULL
assistance	NULL
,	NULL
and	NULL
members	NULL
of	NULL
the	NULL
Bishop	NULL
laboratory	NULL
for	NULL
ongoing	NULL
counsel	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
Grant	NULL
CA	NULL
4338	NULL
from	NULL
the	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
and	NULL
by	NULL
funds	NULL
from	NULL
the	NULL
G.	NULL
W.	NULL
Hooper	NULL
Research	NULL
Foundation	NULL
(	NULL
to	NULL
J.M.B	NULL
.	NULL
)	NULL

.	NULL

S.C.K	NULL
.	NULL

was	NULL
supported	NULL
by	NULL
a	NULL
physician	NULL
fellowship	NULL
from	NULL
the	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
.	NULL

1	NULL
.	NULL

Pedersen-Bjergaard	NULL
,	NULL
J	NULL
.	NULL

&	NULL
Rowley	NULL
,	NULL
J.	NULL
D.	NULL
(	NULL
1994	NULL
)	NULL
Blood	NULL
83	NULL
,	NULL
2780-2786	NULL
.	NULL

2	NULL
.	NULL

Liu	NULL
,	NULL
P.	NULL
,	NULL
Tarle	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
Hajra	NULL
,	NULL
A.	NULL
,	NULL
Claxton	NULL
,	NULL
D.	NULL
F.	NULL
,	NULL
Marlton	NULL
,	NULL
P.	NULL
,	NULL
Freedman	NULL
,	NULL
M.	NULL
,	NULL
Siciliano	NULL
,	NULL
M.	NULL
J	NULL
.	NULL

&	NULL
Collins	NULL
,	NULL
F.	NULL
S.	NULL
(	NULL
1993	NULL
)	NULL
Science	NULL
261	NULL
,	NULL
1041-1044	NULL
.	NULL

3	NULL
.	NULL

Le	NULL
Beau	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
Larson	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
Bitter	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Vardiman	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Golomb	NULL
,	NULL
H.	NULL
M.	NULL
&	NULL
Rowley	NULL
,	NULL
J.	NULL
D.	NULL
(	NULL
1983	NULL
)	NULL
N.	NULL
Engl	NULL
.	NULL

J.	NULL
Med	NULL
.	NULL

309	NULL
,	NULL
630-636	NULL
.	NULL

4	NULL
.	NULL

Langabeer	NULL
,	NULL
S.	NULL
E.	NULL
,	NULL
Walker	NULL
,	NULL
H.	NULL
,	NULL
Gale	NULL
,	NULL
R.	NULL
E.	NULL
,	NULL
Wheatley	NULL
,	NULL
K.	NULL
,	NULL
Burnett	NULL
,	NULL
A.	NULL
K.	NULL
,	NULL
Goldstone	NULL
,	NULL
A.	NULL
H.	NULL
&	NULL
Linch	NULL
,	NULL
D.	NULL
C.	NULL
(	NULL
1997	NULL
)	NULL
Br	NULL
.	NULL

J.	NULL
Haematol	NULL
.	NULL

96	NULL
,	NULL
736-739	NULL
.	NULL

5	NULL
.	NULL

Speck	NULL
,	NULL
N.	NULL
A	NULL
.	NULL

&	NULL
Stacy	NULL
,	NULL
T.	NULL
(	NULL
1995	NULL
)	NULL
in	NULL
Critical	NULL
Reviews	NULL
in	NULL
Eukaryotic	NULL
Gene	NULL
Expression	NULL
,	NULL
eds	NULL
.	NULL

Stein	NULL
,	NULL
G.	NULL
S.	NULL
,	NULL
Stein	NULL
,	NULL
J.	NULL
L.	NULL
&	NULL
Lian	NULL
,	NULL
J	NULL
.	NULL

B	NULL
.	NULL

(	NULL
Begell	NULL
House	NULL
,	NULL
New	NULL
York	NULL
)	NULL
,	NULL
pp	NULL
.	NULL

337-364	NULL
.	NULL

6	NULL
.	NULL

Ito	NULL
,	NULL
Y	NULL
.	NULL

&	NULL
Bae	NULL
,	NULL
S.	NULL
C.	NULL
(	NULL
1997	NULL
)	NULL
in	NULL
Oncogenes	NULL
as	NULL
Transcriptional	NULL
Regulators	NULL
,	NULL
eds	NULL
.	NULL

Yaniv	NULL
,	NULL
M.	NULL
&	NULL
Ghysdael	NULL
,	NULL
J	NULL
.	NULL

(	NULL
Birkhauser	NULL
Verlag	NULL
,	NULL
Basel	NULL
)	NULL
,	NULL
Vol	NULL
.	NULL

2	NULL
,	NULL
pp	NULL
.	NULL

107-132	NULL
.	NULL

7	NULL
.	NULL

Miyoshi	NULL
,	NULL
H.	NULL
,	NULL
Shimizu	NULL
,	NULL
K.	NULL
,	NULL
Kozu	NULL
,	NULL
T.	NULL
,	NULL
Maseki	NULL
,	NULL
N.	NULL
,	NULL
Kaneko	NULL
,	NULL
Y	NULL
.	NULL

&	NULL
Ohki	NULL
,	NULL
M.	NULL
(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88	NULL
,	NULL
10431-10434	NULL
.	NULL

8	NULL
.	NULL

Nucifora	NULL
,	NULL
G.	NULL
,	NULL
Begy	NULL
,	NULL
C.	NULL
R.	NULL
,	NULL
Erickson	NULL
,	NULL
P.	NULL
,	NULL
Drabkin	NULL
,	NULL
H.	NULL
A	NULL
.	NULL

&	NULL
Rowley	NULL
,	NULL
J.	NULL
D.	NULL
(	NULL
1993	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90	NULL
,	NULL
7784-7788	NULL
.	NULL

9	NULL
.	NULL

Mitani	NULL
,	NULL
K.	NULL
,	NULL
Ogawa	NULL
,	NULL
S.	NULL
,	NULL
Tanaka	NULL
,	NULL
T.	NULL
,	NULL
Miyoshi	NULL
,	NULL
H.	NULL
,	NULL
Kurokawa	NULL
,	NULL
M.	NULL
,	NULL
Mano	NULL
,	NULL
H.	NULL
,	NULL
Yazaki	NULL
,	NULL
Y.	NULL
,	NULL
Ohki	NULL
,	NULL
M.	NULL
&	NULL
Hirai	NULL
,	NULL
H.	NULL
(	NULL
1994	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

13	NULL
,	NULL
504-510	NULL
.	NULL

10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
95	NULL
(	NULL
1998	NULL
)	NULL
Romana	NULL
,	NULL
S.	NULL
P.	NULL
,	NULL
Poirel	NULL
,	NULL
H.	NULL
,	NULL
Leconiat	NULL
,	NULL
M.	NULL
,	NULL
Flexor	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Mauchauffe	NULL
,	NULL
M.	NULL
,	NULL
Jonveaux	NULL
,	NULL
P.	NULL
,	NULL
Macintyre	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
Berger	NULL
,	NULL
R.	NULL
&	NULL
Bernard	NULL
,	NULL
O	NULL
.	NULL

A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Blood	NULL
86	NULL
,	NULL
4263-4269	NULL
.	NULL

Golub	NULL
,	NULL
T.	NULL
R.	NULL
,	NULL
Barker	NULL
,	NULL
G.	NULL
F.	NULL
,	NULL
Bohlander	NULL
,	NULL
S.	NULL
K.	NULL
,	NULL
Hiebert	NULL
,	NULL
S.	NULL
W.	NULL
,	NULL
Ward	NULL
,	NULL
D.	NULL
C.	NULL
,	NULL
Bray-Ward	NULL
,	NULL
P.	NULL
,	NULL
Morgan	NULL
,	NULL
E.	NULL
,	NULL
Raimondi	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
Rowley	NULL
,	NULL
J.	NULL
D.	NULL
&	NULL
Gilliland	NULL
,	NULL
D.	NULL
G.	NULL
(	NULL
1995	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92	NULL
,	NULL
4917-4921	NULL
.	NULL

Friedman	NULL
,	NULL
A.	NULL
D.	NULL
(	NULL
1996	NULL
)	NULL
Curr	NULL
.	NULL

Top	NULL
.	NULL

Microbiol	NULL
Immunol	NULL
.	NULL

211	NULL
,	NULL
149-157	NULL
.	NULL

Okuda	NULL
,	NULL
T.	NULL
,	NULL
van	NULL
Deursen	NULL
,	NULL
J.	NULL
,	NULL
Hiebert	NULL
,	NULL
S.	NULL
W.	NULL
,	NULL
Grosveld	NULL
,	NULL
G.	NULL
&	NULL
Downing	NULL
,	NULL
J.	NULL
R.	NULL
(	NULL
1996	NULL
)	NULL
Cell	NULL
84	NULL
,	NULL
321-330	NULL
.	NULL

Wang	NULL
,	NULL
Q.	NULL
,	NULL
Stacy	NULL
,	NULL
T.	NULL
,	NULL
Binder	NULL
,	NULL
M.	NULL
,	NULL
Marin-Padilla	NULL
,	NULL
M.	NULL
,	NULL
Sharpe	NULL
,	NULL
A.	NULL
H.	NULL
&	NULL
Speck	NULL
,	NULL
N.	NULL
A	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
93	NULL
,	NULL
3444-3449	NULL
.	NULL

Wang	NULL
,	NULL
Q.	NULL
,	NULL
Stacy	NULL
,	NULL
T.	NULL
,	NULL
Miller	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Lewis	NULL
,	NULL
A.	NULL
F.	NULL
,	NULL
Gu	NULL
,	NULL
T.	NULL
L.	NULL
,	NULL
Huang	NULL
,	NULL
X.	NULL
,	NULL
Bushweller	NULL
,	NULL
J.	NULL
H.	NULL
,	NULL
Bories	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
Alt	NULL
,	NULL
F.	NULL
W.	NULL
,	NULL
Ryan	NULL
,	NULL
G.	NULL
,	NULL
ef	NULL
al	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Cell	NULL
87	NULL
,	NULL
697-708	NULL
.	NULL

Niki	NULL
,	NULL
M.	NULL
,	NULL
Okada	NULL
,	NULL
H.	NULL
,	NULL
Takano	NULL
,	NULL
H.	NULL
,	NULL
Kuno	NULL
,	NULL
J.	NULL
,	NULL
Tani	NULL
,	NULL
K.	NULL
,	NULL
Hibino	NULL
,	NULL
H.	NULL
,	NULL
Asano	NULL
,	NULL
S.	NULL
,	NULL
Ito	NULL
,	NULL
Y.	NULL
,	NULL
Satake	NULL
,	NULL
M.	NULL
&	NULL
Noda	NULL
,	NULL
T.	NULL
(	NULL
1997	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
94	NULL
,	NULL
5697-5702	NULL
.	NULL

Castilla	NULL
,	NULL
L.	NULL
H.	NULL
,	NULL
Wijmenga	NULL
,	NULL
C.	NULL
,	NULL
Wang	NULL
,	NULL
Q.	NULL
,	NULL
Stacy	NULL
,	NULL
T.	NULL
,	NULL
Speck	NULL
,	NULL
N.	NULL
A.	NULL
,	NULL
Eckhaus	NULL
,	NULL
M.	NULL
,	NULL
Marin-Padilla	NULL
,	NULL
M.	NULL
,	NULL
Collins	NULL
,	NULL
F.	NULL
S.	NULL
,	NULL
Wynshaw-Boris	NULL
,	NULL
A	NULL
.	NULL

&	NULL
Liu	NULL
,	NULL
P.	NULL
P.	NULL
(	NULL
1996	NULL
)	NULL
Cell	NULL
87	NULL
,	NULL
687-696	NULL
.	NULL

Lu	NULL
,	NULL
J.	NULL
,	NULL
Maruyama	NULL
,	NULL
M.	NULL
,	NULL
Satake	NULL
,	NULL
M.	NULL
,	NULL
Bac	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
Ogawa	NULL
,	NULL
E.	NULL
,	NULL
Kagoshima	NULL
,	NULL
H.	NULL
,	NULL
Shigesada	NULL
,	NULL
K.	NULL
&	NULL
Ito	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

15	NULL
,	NULL
1651-1661	NULL
.	NULL

Lagasse	NULL
,	NULL
E.	NULL
&	NULL
Weissman	NULL
,	NULL
I	NULL
L.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

179	NULL
,	NULL
1047-1052	NULL
.	NULL

Hogan	NULL
,	NULL
B.	NULL
,	NULL
Constantini	NULL
,	NULL
F.	NULL
&	NULL
Lacy	NULL
,	NULL
E.	NULL
(	NULL
1994	NULL
)	NULL
Manipulating	NULL
the	NULL
Mouse	NULL
Embryo	NULL
:	NULL
A	NULL
Laboratory	NULL
Manual	NULL
(	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Lab	NULL
.	NULL

Press	NULL
,	NULL
Plainview	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

Taketo	NULL
,	NULL
M.	NULL
,	NULL
Schroeder	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
Mobraaten	NULL
,	NULL
L.	NULL
E.	NULL
,	NULL
Gunning	NULL
,	NULL
K.	NULL
B.	NULL
,	NULL
Hanten	NULL
,	NULL
G.	NULL
,	NULL
Fox	NULL
,	NULL
R.	NULL
R.	NULL
,	NULL
Roderick	NULL
,	NULL
T.	NULL
H.	NULL
,	NULL
Stewart	NULL
,	NULL
C.	NULL
L.	NULL
,	NULL
Lilly	NULL
,	NULL
F.	NULL
,	NULL
Hansen	NULL
,	NULL
C.	NULL
T.	NULL
&	NULL
Overbeck	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88	NULL
,	NULL
2065-2069	NULL
.	NULL

Hawley	NULL
,	NULL
R.	NULL
G.	NULL
,	NULL
Fong	NULL
,	NULL
A	NULL
.	NULL

Z.	NULL
,	NULL
Burns	NULL
,	NULL
B.	NULL
F.	NULL
&	NULL
Hawley	NULL
,	NULL
T.	NULL
S.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

176	NULL
,	NULL
1149-1163	NULL
.	NULL

Pear	NULL
,	NULL
W.	NULL
S.	NULL
,	NULL
Nolan	NULL
,	NULL
G.	NULL
P.	NULL
,	NULL
Scott	NULL
,	NULL
M.	NULL
L.	NULL
&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1993	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90	NULL
,	NULL
8392-8396	NULL
.	NULL

Cepko	NULL
,	NULL
C.	NULL
(	NULL
1992	NULL
)	NULL
in	NULL
Current	NULL
Protocals	NULL
in	NULL
Molecular	NULL
Biology	NULL
,	NULL
eds	NULL
.	NULL

Ausubel	NULL
,	NULL
F.	NULL
M.	NULL
,	NULL
Brent	NULL
,	NULL
R.	NULL
,	NULL
Kingston	NULL
,	NULL
R.	NULL
E.	NULL
,	NULL
Moore	NULL
,	NULL
D.	NULL
D.	NULL
,	NULL
Seidman	NULL
,	NULL
J.	NULL
G.	NULL
,	NULL
Smith	NULL
,	NULL
J	NULL
.	NULL

A	NULL
.	NULL

&	NULL
Struhl	NULL
,	NULL
K.	NULL
(	NULL
Greene/Wiley	NULL
Interscience	NULL
,	NULL
New	NULL
York	NULL
)	NULL
,	NULL
pp	NULL
.	NULL

9.11.5-9.11.6	NULL
.	NULL

Robbins	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Quintrell	NULL
,	NULL
N.	NULL
A	NULL
.	NULL

&	NULL
Bishop	NULL
,	NULL
J.	NULL
M.	NULL
(	NULL
1995	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15	NULL
,	NULL
3507-3515	NULL
.	NULL

Kruisbeck	NULL
,	NULL
A.	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
in	NULL
Current	NULL
Protocols	NULL
in	NULL
Immunology	NULL
,	NULL
eds	NULL
.	NULL

Coligan	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Kruisbeck	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Margulies	NULL
,	NULL
D.	NULL
H.	NULL
,	NULL
Shevach	NULL
,	NULL
E.	NULL
M.	NULL
&	NULL
Strober	NULL
,	NULL
W.	NULL
(	NULL
Greene/Wiley	NULL
Interscience	NULL
,	NULL
New	NULL
York	NULL
)	NULL
,	NULL
p.	NULL
3.1.3	NULL
.	NULL

Groner	NULL
,	NULL
W.	NULL
(	NULL
1985	NULL
)	NULL
in	NULL
New	NULL
Developments	NULL
in	NULL
Flow	NULL
Cytochemistry	NULL
Technology	NULL
,	NULL
ed	NULL
.	NULL

Simson	NULL
,	NULL
E.	NULL
(	NULL
Technicon	NULL
Instruments	NULL
,	NULL
Tarrytown	NULL
,	NULL
NY	NULL
)	NULL
,	NULL
pp	NULL
.	NULL

1-8	NULL
.	NULL

Hart	NULL
,	NULL
P.	NULL
H.	NULL
,	NULL
Spencer	NULL
,	NULL
L.	NULL
K.	NULL
,	NULL
Nulsen	NULL
,	NULL
M.	NULL
F.	NULL
,	NULL
McDonald	NULL
,	NULL
P.	NULL
J	NULL
.	NULL

&	NULL
Finlay-Jones	NULL
,	NULL
J.	NULL
J	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Infect	NULL
.	NULL

Immun	NULL
.	NULL

51	NULL
,	NULL
936-941	NULL
.	NULL

Brown	NULL
,	NULL
D.	NULL
,	NULL
Kogan	NULL
,	NULL
S.	NULL
,	NULL
Lagasse	NULL
,	NULL
E.	NULL
,	NULL
Weissman	NULL
,	NULL
I.	NULL
,	NULL
Alcalay	NULL
,	NULL
M.	NULL
,	NULL
Pelicci	NULL
,	NULL
P.	NULL
G.	NULL
,	NULL
Atwater	NULL
,	NULL
S.	NULL
&	NULL
Bishop	NULL
,	NULL
J.	NULL
M.	NULL
(	NULL
1997	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
94	NULL
,	NULL
2551-2556	NULL
.	NULL

Lagasse	NULL
,	NULL
E.	NULL
&	NULL
Weissman	NULL
,	NULL
I.	NULL
L.	NULL
(	NULL
1992	NULL
)	NULL
Blood	NULL
79	NULL
,	NULL
1907-1915	NULL
.	NULL

Liu	NULL
,	NULL
P.	NULL
P.	NULL
,	NULL
Wijmenga	NULL
,	NULL
C.	NULL
,	NULL
Hajra	NULL
,	NULL
A.	NULL
,	NULL
Blake	NULL
,	NULL
T.	NULL
B.	NULL
,	NULL
Kelley	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
Adelstcin	NULL
,	NULL
R.	NULL
S.	NULL
,	NULL
Bagg	NULL
,	NULL
A.	NULL
,	NULL
Rector	NULL
,	NULL
J.	NULL
,	NULL
Cotelingam	NULL
,	NULL
J.	NULL
,	NULL
Willman	NULL
,	NULL
C.	NULL
L.	NULL
&	NULL
Collins	NULL
,	NULL
F.	NULL
S.	NULL
(	NULL
1996	NULL
)	NULL
Genes	NULL
Chromosomes	NULL
Cancer	NULL
16	NULL
,	NULL
77-87	NULL
.	NULL

Cao	NULL
,	NULL
W.	NULL
,	NULL
Britos-Bray	NULL
,	NULL
M.	NULL
,	NULL
Claxton	NULL
,	NULL
D.	NULL
F.	NULL
,	NULL
Kelley	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
Speck	NULL
,	NULL
N.	NULL
A.	NULL
,	NULL
Liu	NULL
,	NULL
P.	NULL
P.	NULL
&	NULL
Friedman	NULL
,	NULL
A.	NULL
D.	NULL
(	NULL
1997	NULL
)	NULL
Oncogene	NULL
15	NULL
,	NULL
1315-1327	NULL
.	NULL

Kanno	NULL
,	NULL
Y.	NULL
,	NULL
Kanno	NULL
,	NULL
T.	NULL
,	NULL
Sakakura	NULL
,	NULL
C.	NULL
,	NULL
Bae	NULL
,	NULL
S.	NULL
C.	NULL
&	NULL
Ito	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
,	NULL
4252-4261	NULL
.	NULL

Sanderson	NULL
,	NULL
J.	NULL
H.	NULL
&	NULL
Phillips	NULL
,	NULL
C.	NULL
E.	NULL
(	NULL
1981	NULL
)	NULL
An	NULL
Aflas	NULL
of	NULL
Laboratory	NULL
Animal	NULL
Haematology	NULL
(	NULL
Clarendon	NULL
,	NULL
Oxford	NULL
)	NULL
.	NULL

Nuchprayoon	NULL
,	NULL
I.	NULL
,	NULL
Meyers	NULL
,	NULL
S.	NULL
,	NULL
Scott	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
Suzow	NULL
,	NULL
J.	NULL
,	NULL
Hicbert	NULL
,	NULL
S.	NULL
&	NULL
Friedman	NULL
,	NULL
A.	NULL
D.	NULL
(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
5558-5568	NULL
.	NULL

Liu	NULL
,	NULL
E.	NULL
T.	NULL
(	NULL
1990	NULL
)	NULL
Clin	NULL
.	NULL

Lab	NULL
.	NULL

Med	NULL
.	NULL

10	NULL
,	NULL
797-807	NULL
.	NULL

Tien	NULL
,	NULL
H.	NULL
F.	NULL
,	NULL
Wang	NULL
,	NULL
C.	NULL
H.	NULL
,	NULL
Lin	NULL
,	NULL
M.	NULL
T.	NULL
,	NULL
Lee	NULL
,	NULL
F.	NULL
Y.	NULL
,	NULL
Liu	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
Chuang	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Chen	NULL
,	NULL
Y.	NULL
C.	NULL
,	NULL
Shen	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
Lin	NULL
,	NULL
K.	NULL
H.	NULL
&	NULL
Lin	NULL
,	NULL
D.	NULL
T.	NULL
(	NULL
1995	NULL
)	NULL
Cancer	NULL
Genet	NULL
.	NULL

Cytogenet	NULL
.	NULL

84	NULL
,	NULL
60-68	NULL
.	NULL

Liu	NULL
,	NULL
P.	NULL
,	NULL
Seidel	NULL
,	NULL
N.	NULL
,	NULL
Bodine	NULL
,	NULL
D.	NULL
,	NULL
Speck	NULL
,	NULL
N.	NULL
,	NULL
Tarle	NULL
,	NULL
S.	NULL
&	NULL
Collins	NULL
,	NULL
F.	NULL
S.	NULL
(	NULL
1994	NULL
)	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Symp	NULL
.	NULL

Quant	NULL
.	NULL

Biol	NULL
.	NULL

59	NULL
,	NULL
547-553	NULL
.	NULL

Langdon	NULL
,	NULL
W.	NULL
Y.	NULL
,	NULL
Harris	NULL
,	NULL
A.	NULL
W.	NULL
,	NULL
Cory	NULL
,	NULL
S.	NULL
&	NULL
Adams	NULL
,	NULL
J.	NULL
M.	NULL
(	NULL
1986	NULL
)	NULL
Cell	NULL
47	NULL
,	NULL
11-18	NULL
.	NULL

Abbondanzo	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
Gray	NULL
,	NULL
R.	NULL
G.	NULL
,	NULL
Whang-Peng	NULL
,	NULL
J	NULL
.	NULL

&	NULL
Jacobson	NULL
,	NULL
R.	NULL
J	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Arch	NULL
.	NULL

Pathol	NULL
.	NULL

Lab	NULL
.	NULL

Med	NULL
.	NULL

111	NULL
,	NULL
330-332	NULL
.	NULL

Horiike	NULL
,	NULL
S.	NULL
,	NULL
Misawa	NULL
,	NULL
S.	NULL
,	NULL
Nishida	NULL
,	NULL
K.	NULL
,	NULL
Nishigaki	NULL
,	NULL
H.	NULL
,	NULL
Tsuda	NULL
,	NULL
S.	NULL
,	NULL
Taniwaki	NULL
,	NULL
M.	NULL
,	NULL
Takino	NULL
,	NULL
T.	NULL
&	NULL
Abe	NULL
,	NULL
T.	NULL
(	NULL
1989	NULL
)	NULL
Acta	NULL
Haematol	NULL
.	NULL

82	NULL
,	NULL
161-164	NULL
.	NULL

Estey	NULL
,	NULL
E.	NULL
,	NULL
Trujillo	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Cork	NULL
,	NULL
A.	NULL
,	NULL
O'Brien	NULL
,	NULL
S.	NULL
,	NULL
Beran	NULL
,	NULL
M.	NULL
,	NULL
Kantarjian	NULL
,	NULL
H.	NULL
,	NULL
Keating	NULL
,	NULL
M.	NULL
,	NULL
Freireich	NULL
,	NULL
E.	NULL
J	NULL
.	NULL

&	NULL
Stass	NULL
,	NULL
S.	NULL
(	NULL
1992	NULL
)	NULL
Hematol	NULL
.	NULL

Pathol	NULL
.	NULL

6	NULL
,	NULL
43-48	NULL
.	NULL

Taj	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
Ross	NULL
,	NULL
F.	NULL
M.	NULL
,	NULL
Vickers	NULL
,	NULL
M.	NULL
,	NULL
Choudhury	NULL
,	NULL
D.	NULL
N.	NULL
,	NULL
Harvey	NULL
,	NULL
J.	NULL
F.	NULL
,	NULL
Barber	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
Barton	NULL
,	NULL
C.	NULL
&	NULL
Smith	NULL
,	NULL
A.	NULL
G.	NULL
(	NULL
1995	NULL
)	NULL
Br	NULL
.	NULL

J.	NULL
Haematol	NULL
.	NULL

89	NULL
,	NULL
890-892	NULL
.	NULL

Okuda	NULL
,	NULL
T.	NULL
,	NULL
Cai	NULL
,	NULL
Z.	NULL
,	NULL
Yang	NULL
,	NULL
S.	NULL
,	NULL
Lenny	NULL
,	NULL
N.	NULL
,	NULL
Lyu	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
van	NULL
Deursen	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Harada	NULL
,	NULL
H.	NULL
&	NULL
Downing	NULL
,	NULL
J.	NULL
R.	NULL
(	NULL
1998	NULL
)	NULL
Blood	NULL
91	NULL
,	NULL
3134-3143	NULL
.	NULL

